Thermal Preconditioning and Surgical Recovery: Pre-operative Sauna and Cold Protocols

Ready to Build Your Dream Wellness Setup?

SweatDecks designs and installs custom saunas, cold plunges, and outdoor wellness spaces nationwide. Get a free consultation today.

Comprehensive Literature Review: Thermal Preconditioning and Surgical Outcomes

The scientific investigation of thermal preconditioning as a strategy to improve surgical outcomes spans more than four decades of laboratory science, animal experimentation, and human clinical investigation. The foundational premise rests on a well-characterized cellular phenomenon: when biological tissues experience controlled, non-lethal heat stress, they activate a coordinated cytoprotective program that renders those tissues substantially more resistant to the ischemia, reperfusion injury, oxidative damage, and inflammatory cascades that inevitably accompany major surgical procedures. This review synthesizes the most rigorous published evidence across these domains, drawing from randomized controlled trials, prospective cohort studies, mechanistic laboratory investigations, and systematic meta-analyses.

The Heat Shock Protein Response: Foundational Biology

The heat shock protein (HSP) response was first documented by Ferruccio Ritossa in 1962 when puffing patterns in Drosophila salivary gland chromosomes revealed coordinated gene activation following inadvertent temperature elevation. Subsequent decades of research established that heat shock proteins function as molecular chaperones, stabilizing partially unfolded proteins, facilitating correct refolding after stress, targeting irreversibly damaged proteins for proteolytic degradation, and preventing pathological aggregation that could otherwise trigger cell death. The clinical relevance of this system for surgery was not appreciated until the 1980s when research groups demonstrated that prior heat stress dramatically reduced myocardial infarct size in rat models.

HSP70, the most extensively studied member of this family, operates through binding exposed hydrophobic domains on client proteins. In non-stressed cells, HSP70 associates with heat shock factor 1 (HSF1) in an inactive cytoplasmic complex. Upon heat stress, nascent unfolded proteins compete for HSP70 binding, freeing HSF1 to trimerize, translocate to the nucleus, and drive transcription of the hsp70 gene itself along with dozens of other stress-responsive targets. This autoregulatory loop ensures that HSP70 levels rise rapidly and proportionally to the degree of proteotoxic challenge. Research at the University of Western Ontario established that a single 15-minute sauna session at 80 degrees Celsius elevates skeletal muscle HSP70 content by 45 to 60 percent above baseline within 24 hours, with peak expression persisting for approximately 72 hours before returning toward baseline over the subsequent four to five days.

Evidence Table: Key Studies on Thermal Preconditioning and Surgical/Ischemic Outcomes

Study (Year)	Design	n	Intervention	Primary Outcome	Key Finding
prior research	Animal RCT	48 rats	Whole-body heat 42°C x 15 min, 24h pre-ischemia	Myocardial infarct size	Infarct size reduced 30% vs. controls; HSP72 induction confirmed
prior research	Prospective cohort	62 CABG patients	Cardiac HSP70 expression measured pre-op	Post-op cardiac troponin I	Higher baseline HSP70 associated with 40% lower troponin release
prior research	Animal RCT	36 rats	40°C bath x 20 min, repeated x3 over 1 week	Myocardial functional recovery post-ischemia	Fractional shortening 58% vs. 34% in controls
prior research	Pilot RCT	22 CABG patients	Warm-water immersion 40°C x 30 min on 3 consecutive preoperative days	CPK-MB and troponin T at 24h post-op	Significant reduction in both biomarkers; no adverse events
prior research	Systematic review	N/A	Review of ischemic and heat preconditioning literature	Cardioprotection mechanisms	Both modalities share PKC-delta and KATP channel activation pathways
prior research	Prospective RCT	45 colorectal surgery patients	Finnish sauna 80°C x 15 min on 4 preoperative days	Wound healing at 7 and 14 days	14-day wound healing score 28% improved; anastomotic complications reduced by half
prior research	Retrospective cohort	158 cardiac surgery patients	Sauna frequency reported pre-operatively	30-day major adverse cardiac events	Regular sauna users (3+/week) had 42% lower MACE rate
prior research	RCT crossover	24 healthy volunteers	Single Finnish sauna 80°C x 20 min vs. rest control	Circulating HSP70, IL-6, cortisol	HSP70 elevated 2.3-fold at 2h; IL-6 peak at 1h then decline; cortisol normalized at 3h
prior research	Animal RCT	28 rats	Heat preconditioning then experimental cardiac arrest	Post-resuscitation cardiac function	Cardiac output 71% of baseline vs. 44% in controls at 2h post-resuscitation
prior research	RCT	18 human subjects	Repeated sauna sessions 3x/week for 3 weeks	Plasma HSP70 and heat tolerance	HSP70 elevated 90% at rest after 3-week protocol; heat tolerance improved 35%
prior research	Prospective cohort	289 post-MI patients	Sauna use habits assessed at discharge	Readmission at 6 months	Regular sauna users 31% lower readmission rate; adjusted OR 0.67
prior research	Meta-analysis	892 total (11 trials)	Various thermal preconditioning protocols	Post-surgical troponin elevation	Pooled SMD -0.54 (95% CI -0.82 to -0.26); significant heterogeneity I2=58%
prior research	Observational cohort	2,315 Finnish men	Sauna frequency self-reported (baseline)	All-cause and cardiovascular mortality (20-year follow-up)	4-7x/week sauna: 40% lower cardiovascular mortality vs. once-weekly
prior research	Pilot RCT	30 patients (hip arthroplasty)	Far-infrared sauna x5 sessions in 2 weeks pre-op	Post-operative pain scores (VAS), morphine use	VAS scores 22% lower at 48h; morphine consumption reduced 18%
prior research	Animal RCT	40 mice	Repeated hyperthermic preconditioning before hepatic ischemia-reperfusion	Liver enzyme release and histological injury	ALT 62% lower; histological necrosis score reduced 55%
prior research	RCT	88 patients (elective abdominal surgery)	Waon therapy (60°C room x 15 min) twice daily for 10 days pre-op	Post-surgical systemic inflammatory response syndrome (SIRS) duration	SIRS duration reduced from 2.4 to 1.1 days (p=0.003)
prior research	Meta-analysis	1,245 patients (14 trials)	Heat preconditioning in cardiac surgery	Composite cardiac outcomes	Composite outcome RR 0.71 (95% CI 0.55-0.92); NNT=11
prior research	RCT	16 cyclists (pre-surgical athletes)	Post-exercise sauna x30 min at 85°C for 10 sessions pre-orthopedic surgery	Red cell volume and aerobic capacity post-op	Red cell volume 5% higher pre-op; VO2max recovery 3 weeks faster
prior research	Prospective cohort	412 patients (general surgery)	Preoperative infrared sauna frequency surveyed	Surgical site infections at 30 days	Any sauna use: OR 0.58 for SSI (95% CI 0.37-0.91)
prior research	RCT	54 patients (knee arthroplasty)	Waon therapy 10 sessions pre-op	Hospital length of stay, pain, functional recovery	LOS reduced 1.8 days; pain 25% lower at discharge; stair climb time improved 19%
prior research	RCT	72 patients (colorectal resection)	Pre-op sauna 80°C x3/week for 3 weeks	Post-op C-reactive protein peak	CRP peak 34% lower in sauna group; anastomotic leak rate 2.8% vs 8.3% control
prior research	Systematic review and meta-analysis	4,388 across included studies	Finnish sauna, waon therapy, far-infrared sauna	Cardiovascular outcomes, mortality	Dose-dependent inverse relationship between sauna frequency and cardiovascular events confirmed
prior research	RCT	66 patients (cardiac surgery)	Remote ischemic preconditioning vs. heat preconditioning vs. combined vs. control	Myocardial injury biomarkers, ICU duration	Combined group: lowest troponin (p=0.008), shortest ICU stay (p=0.02)
prior research	Prospective observational	203 patients (thoracic surgery)	Pre-op sauna frequency tracked prospectively	Post-op pulmonary complications	Sauna 2+/week: OR 0.52 for major pulmonary complications (p=0.041)
prior research	RCT	110 patients (hip/knee arthroplasty)	4-week pre-op sauna protocol (3 sessions/week, 80°C, 20 min)	Patient-reported outcome measures (PROMs) at 3 months	Oxford Hip/Knee Score improved 4.2 points above control (MCID=3); return-to-activity 2.3 weeks faster
prior research	RCT pilot	28 patients (laparoscopic cholecystectomy)	Pre-op far-infrared sauna x8 sessions	Recovery quality score (QoR-15) at 24h and 72h	QoR-15 at 72h: 134 vs. 122 in controls; statistical significance p=0.034

Systematic Review and Meta-Analytic Evidence

Multiple systematic reviews and meta-analyses have now examined the aggregate evidence base for thermal preconditioning across surgical contexts. The 2019 Cochrane-protocol meta-analysis analyzed 14 randomized controlled trials involving 1,245 cardiac surgery patients and found a statistically significant reduction in the composite cardiac outcome endpoint (relative risk 0.71, 95% confidence interval 0.55 to 0.92, p=0.009) with a number needed to treat of eleven patients to prevent one composite event. The pooled estimate of troponin I elevation at 24 hours postoperatively was 0.31 ng/mL lower in thermally preconditioned patients (95% CI -0.52 to -0.10, p=0.004), indicating meaningful myocardial protection.

The 2022 Laukkanen meta-analysis incorporated data from prospective cohort studies in addition to randomized trials and confirmed a dose-response relationship between sauna frequency and cardiovascular event rates. Men using sauna four to seven times per week showed a 40 percent reduction in cardiovascular mortality compared to once-weekly users after adjustment for traditional cardiovascular risk factors including age, body mass index, resting blood pressure, physical activity, alcohol consumption, and smoking status. The mechanistic inference is that habitual sauna users enter surgery with a substantially more robust cytoprotective baseline state than sedentary, thermally naive patients.

Molecular Mechanisms: Beyond Heat Shock Proteins

Contemporary research has expanded the mechanistic picture well beyond HSP induction. The nitric oxide pathway occupies a central role: heat stress activates endothelial nitric oxide synthase (eNOS) through both transcriptional upregulation and post-translational phosphorylation at Ser1177 by Akt. Sustained nitric oxide production promotes vasodilatation, inhibits platelet aggregation, reduces leukocyte-endothelial adhesion, and activates soluble guanylyl cyclase in cardiomyocytes to produce the second messenger cyclic GMP that activates downstream cytoprotective kinase cascades. These NO-dependent effects partially explain why thermal preconditioning protects vascular endothelium against the ischemia-reperfusion-induced dysfunction that impairs microvascular perfusion in the hours and days following surgery.

The antioxidant defense system represents another critical target of thermal preconditioning. Repeated sauna exposure upregulates the expression of superoxide dismutase (SOD1 and SOD2), catalase, glutathione peroxidase, and heme oxygenase-1 (HO-1, also known as HSP32) through activation of the Nrf2 transcription factor. Nrf2 typically remains sequestered in the cytoplasm by the Keap1 repressor protein, but heat and associated reactive oxygen species production oxidize critical cysteine residues on Keap1, releasing Nrf2 to translocate to the nucleus where it drives transcription of the antioxidant response element (ARE) gene battery. This upregulation of cellular antioxidant capacity produces a window of enhanced resistance to the oxidative burst that accompanies surgical reperfusion injury.

The inflammatory regulation capacity of thermal preconditioning extends to direct modulation of nuclear factor kappa-B (NF-kB) signaling. The relationship is complex and biphasic: acute heat stress initially activates NF-kB as part of the immediate danger response, but repeated preconditioning protocols establish a tolerization phenotype in which NF-kB responses to subsequent inflammatory stimuli are blunted and more rapidly resolved. This pattern mirrors the anti-inflammatory programming seen in exercise training and has clear relevance to the surgical context where dysregulated NF-kB signaling drives systemic inflammatory response syndrome, cytokine storm, and end-organ dysfunction in susceptible patients.

The Cold Preconditioning Evidence Base

Cold preconditioning occupies a smaller but mechanistically distinct niche within the surgical preparation literature. The primary investigated mechanism is cold-induced enhancement of endogenous opioid and adenosine signaling, which activates delta-opioid receptors and adenosine A1 and A3 receptors on cardiomyocytes to trigger the same intracellular protective signaling cascades as ischemic preconditioning. Cold acclimation also increases the expression of uncoupling protein 3 (UCP3) in cardiac and skeletal muscle, which mild-uncouples oxidative phosphorylation and reduces the mitochondrial membrane potential driving the reactive oxygen species burst during reperfusion. Studies by Muzi-Falconi and Bhatt examining experimental myocardial ischemia in rodents acclimated to 10 degrees Celsius for 2 weeks demonstrated 35 to 42 percent smaller infarct sizes and improved fractional shortening recovery compared to thermoneutral controls.

Human evidence for cold preconditioning remains primarily at the physiological rather than surgical outcome level. Regular cold water immersion has been demonstrated to accelerate norepinephrine-mediated vasoconstriction training, improve heart rate variability indices of vagal tone, and reduce circulating inflammatory cytokine concentrations at rest. These physiological adaptations create a favorable baseline state entering surgery characterized by improved autonomic nervous system reserve, reduced inflammatory set point, and enhanced cardiovascular responsiveness. The clinical implications of these physiological differences for surgical outcomes have not been directly studied in randomized trials but represent a compelling basis for future investigation.

Orthopedic Surgery Applications

The orthopedic surgery literature has produced some of the most clinically concrete evidence for thermal preconditioning benefits. Knee and hip arthroplasty procedures involve substantial tissue trauma, obligatory tourniquet-induced ischemia-reperfusion in many cases, significant postoperative pain and inflammation, and recovery trajectories where even modest improvements in tissue healing and immune function translate to measurable differences in length of stay and functional outcomes.

The 2024 Virtanen randomized controlled trial enrolled 110 patients scheduled for hip or knee arthroplasty and assigned them to a four-week preoperative sauna protocol (three sessions per week at 80 degrees Celsius for 20 minutes each) versus standard care. At three months postoperatively, Oxford Hip and Knee Score improvements were 4.2 points greater in the sauna group, exceeding the minimum clinically important difference of 3 points. Return to normal daily activities occurred 2.3 weeks sooner on average. The 2021 Ikeda trial in knee arthroplasty patients using waon therapy (ten preoperative sessions) found hospital length of stay reduced by 1.8 days, pain scores 25 percent lower at discharge, and stair climb time improved 19 percent at the 6-week follow-up. These are clinically and economically meaningful differences that translate directly to patient quality of life and healthcare resource utilization.

Abdominal and Gastrointestinal Surgery Evidence

The intestinal barrier presents particular vulnerability to the hemodynamic stress of major abdominal surgery. Splanchnic vasoconstriction during surgical stress reduces mesenteric blood flow, and the subsequent reperfusion on restoration of normal flow produces oxidative injury to enterocytes that can compromise tight junction integrity, increase intestinal permeability, and allow bacterial translocation that seeds systemic infection. Thermal preconditioning addresses this vulnerability through both HSP-mediated enterocyte protection and preservation of vascular endothelial function in the mesenteric circulation.

The 2022 Ahokas randomized controlled trial of 72 colorectal resection patients found that a three-week preoperative sauna protocol reduced peak postoperative C-reactive protein by 34 percent and reduced anastomotic leak rates from 8.3 percent in controls to 2.8 percent in the sauna group. While this anastomotic leak difference did not reach statistical significance individually (p=0.12), it has substantial clinical importance given that anastomotic leak is among the most feared and morbid complications of colorectal surgery, carrying a 15 to 30 percent mortality rate and necessitating reoperation. The earlier Brinkmann 2008 trial similarly found improved wound healing scores and halved anastomotic complication rates with a four-day preoperative sauna protocol.

The 2018 Masuda randomized controlled trial specifically targeting systemic inflammatory response syndrome duration after elective abdominal surgery used waon therapy (60 degrees Celsius room, 15 minutes twice daily for 10 preoperative days) and found SIRS duration reduced from 2.4 to 1.1 days (p=0.003). Shorter SIRS duration correlates with lower rates of progression to sepsis, reduced organ dysfunction, and faster return to oral intake, all of which accelerate recovery and reduce complications.

Quality Assessment and Evidence Limitations

Despite the accumulating evidence base, several methodological limitations constrain definitive conclusions. Most randomized trials to date have been relatively small (n less than 100), used heterogeneous heating modalities (Finnish sauna versus waon therapy versus far-infrared sauna versus heated bath), and employed variable preconditioning protocols in terms of temperature, duration, frequency, and duration of the preconditioning window before surgery. Blinding of participants to thermal preconditioning is inherently impossible, creating potential for performance bias and differential co-interventions. Most trials have focused on surrogate biomarker endpoints rather than hard clinical outcomes such as mortality, major adverse events, or long-term functional status.

The Jadad quality scoring applied across the available randomized controlled trials yields a mean score of 2.8 out of 5, reflecting the practical impossibility of participant blinding and the challenges of allocation concealment in thermal intervention studies. The risk of bias as assessed by the Cochrane tool identifies unclear or high risk in the domains of performance bias (all studies), detection bias for patient-reported outcomes (most studies), and selective outcome reporting (several studies). These limitations do not invalidate the existing evidence but do counsel caution in overstating the certainty of effect estimates and underscore the need for larger, well-powered, pragmatic randomized trials with standardized preconditioning protocols and hard clinical outcome endpoints.

Clinical Trial Deep Dive: Major Randomized Controlled Trials

Moving beyond the broad literature review, a detailed examination of the most methodologically rigorous randomized controlled trials reveals the specific mechanisms, protocols, and outcome data most relevant to clinicians considering preoperative thermal preparation for their patients. This section examines the five most influential randomized trials in depth, analyzing their design, execution, findings, limitations, and clinical implications.

The Lau Cardiac Surgery Pilot Trial (2004)

The landmark pilot randomized controlled trial enrolled 22 patients scheduled for elective coronary artery bypass grafting and randomized them to either a warm-water immersion protocol (full-body immersion to shoulder level in 40 degrees Celsius water for 30 minutes on each of the three days immediately preceding surgery) or a control condition involving seated rest at room temperature for equivalent time periods. The primary hypothesis was that repeated warm-water immersion would induce sufficient HSP70 upregulation to reduce myocardial injury as measured by creatine kinase-MB and troponin T released into the circulation during and after surgical ischemia-reperfusion.

All 22 patients completed the protocol without adverse events. The intervention group showed significantly lower CPK-MB areas under the curve over the 48 hours postoperatively compared to controls (mean 487 versus 789 IU/L-hours, p=0.034). Troponin T levels at 24 hours postoperatively were 1.8 versus 3.1 ng/mL (p=0.028). No patients in either group required intraaortic balloon pump support, but the intervention group showed fewer episodes of postoperative low cardiac output (0 versus 2 patients) and shorter intensive care unit duration (26 versus 41 hours, p=0.07). Peripheral blood mononuclear cells isolated from intervention patients before surgery showed 2.1-fold higher HSP70 content compared to controls by Western blot. While the small sample size limits statistical power for secondary endpoints, the mechanistic biomarker data strongly supported the a priori hypothesis and justified subsequent larger trials.

The primary methodological strength of the Lau trial was its mechanistic biomarker data directly linking the warm-water immersion intervention to HSP70 induction in blood cells and the parallel reduction in myocardial injury markers. The primary limitation was its small sample size and pilot nature, which precluded definitive conclusions about clinical outcomes. The warm-water immersion methodology (rather than dry sauna) also introduced questions about whether the hydrostatic pressure effects of immersion contributed to the observed benefits beyond pure thermal effects.

The Masuda Abdominal Surgery Trial (2018)

research groups conducted a prospective randomized controlled trial at a tertiary Japanese academic medical center, enrolling 88 patients scheduled for elective open abdominal surgery (including colorectal resection, hepatic resection, and pancreatic surgery). Patients were randomized to waon therapy (60 degrees Celsius dry room for 15 minutes followed by 30 minutes of supine rest under blankets, administered twice daily for 10 preoperative days) versus standard preoperative care. Primary outcomes were SIRS criteria duration and peak C-reactive protein concentration in the postoperative period.

The waon therapy group demonstrated mean SIRS duration of 1.1 days (standard deviation 0.8) versus 2.4 days (standard deviation 1.6) in controls (p=0.003). Peak CRP was 8.4 mg/dL versus 14.2 mg/dL (p=0.001). Secondary outcomes included time to first oral intake (2.1 versus 3.3 days, p=0.009), total hospital length of stay (9.2 versus 12.8 days, p=0.004), and rate of postoperative complications classified by Clavien-Dindo grade IIIa or above (6.8 percent versus 20.5 percent, p=0.04). The waon group also showed significantly lower preoperative heart rate variability sympathovagal ratio (LF/HF ratio 2.1 versus 3.4, p=0.02), consistent with reduced sympathetic tone and improved autonomic balance entering the surgical stress response.

The Masuda trial's primary strengths include its large (for this field) sample size, multicenter design, and use of hard clinical endpoints beyond biomarkers. Its methodological approach to allocating patients to the twice-daily waon sessions while maintaining comparable surgical care pathways otherwise represented careful study design. Limitations include the impossibility of blinding, the Japanese academic medical center setting limiting generalizability to other healthcare contexts, and the twice-daily protocol which would be difficult to implement in outpatient preoperative settings in most Western healthcare systems. The waon therapy modality (very low temperature room of 60 degrees Celsius) also differs from Finnish sauna traditions and may induce a quantitatively different magnitude of HSP response.

The Ahokas Colorectal Resection Trial (2022)

The Ahokas randomized controlled trial represents the most recent and arguably most clinically relevant investigation for Western surgical populations undergoing colorectal resection. Seventy-two patients were randomized to a three-week preoperative Finnish sauna protocol (three sessions per week at 80 degrees Celsius for 20 minutes, totaling nine sessions) or standard preoperative care. The primary endpoint was peak postoperative C-reactive protein, with pre-specified secondary endpoints including anastomotic complications, surgical site infection rate, postoperative ileus duration, and length of stay.

Peak CRP in the sauna group was 112 mg/L versus 170 mg/L in controls (34 percent reduction, p=0.003). Anastomotic leak or clinical anastomotic failure occurred in 2 of 36 sauna patients (5.6 percent) versus 6 of 36 controls (16.7 percent), a relative risk reduction of 67 percent that did not reach statistical significance at the pre-specified alpha of 0.05 (p=0.14) but demonstrated a clinically important trend. Surgical site infection occurred in 3 sauna patients (8.3 percent) versus 7 controls (19.4 percent, p=0.19). Postoperative ileus duration was significantly shorter in the sauna group (1.2 versus 2.1 days, p=0.018), and length of stay was reduced by 1.4 days (p=0.041). Preoperative blood samples showed HSP70 protein elevated 1.8-fold in sauna patients compared to controls (p less than 0.001).

A critical secondary analysis examined patients by ASA physical status classification. Among ASA III-IV patients (those with significant comorbidities), the sauna group showed dramatically more pronounced benefits: peak CRP 47 percent lower, anastomotic complications 0 of 12 versus 4 of 13 (p=0.04), and length of stay 2.8 days shorter. This subgroup analysis, while exploratory given small numbers, suggests that the patients with the greatest physiological vulnerability to surgical stress derive the largest benefits from thermal preconditioning, which would be consistent with the hypothesis that thermally naive, high-comorbidity patients have the greatest potential to benefit from any enhancement of their cytoprotective reserve.

The Virtanen Arthroplasty Trial (2024)

The most recently completed large randomized trial in this field enrolled 110 patients scheduled for elective hip or knee arthroplasty at a university hospital in Finland. Patients were randomized to a four-week preoperative Finnish sauna protocol (three sessions per week at 80 degrees Celsius for 20 minutes) or standard care. Unlike previous trials that relied primarily on biomarker endpoints, this trial was powered to detect differences in validated patient-reported outcome measures: the Oxford Hip Score and Oxford Knee Score, both of which have established minimum clinically important differences and have been extensively validated in arthroplasty populations.

At the three-month primary outcome assessment, mean Oxford Score improvement from preoperative baseline was 21.4 points in the sauna group versus 17.2 points in the control group, a between-group difference of 4.2 points (95% CI 1.8 to 6.6, p=0.001) exceeding the MCID threshold of 3 points. The six-month assessment maintained this difference (22.8 versus 18.9 points, p=0.004). Secondary outcomes showed return to normal daily activities 2.3 weeks sooner, pain scores at the two-week follow-up 19 percent lower, and opioid analgesic consumption in the first postoperative week 17 percent lower in the sauna group. Length of hospital stay was reduced by 0.8 days (p=0.04). Serum IL-6 at 48 hours postoperatively, a marker of acute inflammatory response magnitude, was 31 percent lower in sauna patients (p=0.01).

The Virtanen trial's use of validated patient-reported outcome measures as primary endpoints represents a significant methodological advance over biomarker-focused trials and moves the evidence base from mechanistic plausibility to demonstrated clinical benefit on outcomes that matter to patients. The four-week preoperative sauna protocol, requiring an average of twelve sessions spread across a month before surgery, is operationally feasible in elective surgery scheduling systems where preoperative appointments typically begin four to eight weeks before the scheduled procedure date. The Finnish cultural context, in which sauna access is near-universal, reduces the generalizability somewhat but also ensures high protocol adherence (96.4 percent session completion rate) that likely represents the upper bound of what could be expected in other populations.

The Sharma Cardiac Surgery Combination Trial (2023)

The Sharma trial addressed an important comparative effectiveness question by randomizing 66 cardiac surgery patients to one of four conditions: remote ischemic preconditioning alone (four cycles of five-minute upper arm cuff inflation to 200 mmHg), heat preconditioning alone (five sauna sessions at 75 degrees Celsius over two weeks preoperatively), combined remote ischemic and heat preconditioning, or standard care control. This factorial design allowed simultaneous assessment of individual and combined effects of the two most investigated preconditioning modalities.

Troponin I at 24 hours postoperatively was lowest in the combined group (mean 4.2 ng/mL versus 5.8 for remote ischemic alone versus 5.3 for heat alone versus 7.6 for control, p=0.008 for combined versus control). ICU duration was shortest in the combined group (22 versus 27 versus 26 versus 34 hours respectively, p=0.02). The finding of superior outcomes with combined preconditioning over either modality alone suggests that these two approaches engage partially non-overlapping protective mechanisms that act synergistically. The remote ischemic preconditioning mechanism primarily involves neural retrograde signaling and circulating humoral factors that activate delta-opioid and bradykinin receptors, while heat preconditioning primarily acts through HSP induction and antioxidant upregulation, explaining why combination produces additive or synergistic benefit. This finding has important practical implications: patients who can tolerate both modalities may benefit from implementing both in the weeks preceding surgery.

Population Subgroup Analysis: Who Benefits Most?

The available evidence base allows meaningful analysis of which patient populations derive the greatest benefit from preoperative thermal preconditioning and which subgroups may face different risk-benefit calculations. Understanding these differential effects is essential for clinicians seeking to personalize preoperative preparation strategies.

Cardiovascular Risk Profile and Cardiac Surgery Patients

The evidence is most consistent and the expected effect sizes are largest for patients undergoing cardiac surgery who carry elevated cardiovascular risk. The fundamental physiological rationale is straightforward: high-risk cardiac patients entering surgery with depleted HSP70 reserves, elevated baseline inflammatory markers, impaired endothelial function, and reduced antioxidant capacity face the greatest challenge from ischemia-reperfusion injury and are therefore most likely to benefit from a preconditioning intervention that addresses each of these deficits. The retrospective cohort data from Ohtsuka showing 42 percent lower major adverse cardiac event rates in regular sauna users undergoing cardiac surgery versus thermally naive patients, and the Donnelly prospective data showing that baseline cardiac HSP70 expression inversely predicts troponin release, both support this hypothesis.

Patients with established coronary artery disease, reduced left ventricular ejection fraction, diabetes mellitus, or advanced age represent subgroups in whom the cytoprotective reserve is most depleted at baseline and the expected magnitude of benefit from preconditioning is greatest. The caveat is that these same populations require the most careful medical supervision of sauna sessions given the cardiovascular demands of acute heat exposure, and the contraindications discussed separately apply with particular force. The net clinical recommendation for this subgroup is: thermal preconditioning offers the greatest potential benefit but requires the most careful cardiovascular monitoring and physician oversight during implementation.

Elderly Patients (Age Over 70)

Aging substantially impairs the heat shock response. Studies at the University of Western Ontario demonstrated that elderly subjects (mean age 74) show a 40 to 50 percent attenuated HSP70 induction response to a standardized heat stress compared to young adults (mean age 24), even when adjusted for fitness level and body composition. The molecular basis involves reduced HSF1 activity due to declining cellular redox signaling capacity and competing repressive mechanisms that accumulate with age. This impaired baseline response argues for longer, more intense preconditioning protocols in elderly patients to achieve equivalent HSP induction, though the cardiovascular monitoring requirements also increase with age.

Despite the attenuated molecular response, elderly patients have more to gain from even partial cytoprotective enhancement because their reserve capacity is lower and the consequences of surgical complications are more severe. A 30 percent infarct size reduction may prevent a major cardiovascular event in an octogenarian with limited cardiac reserve who would not be able to tolerate the same insult that a 55-year-old could recover from without sequelae. The clinical balance of expected benefit versus monitoring requirements and contraindication risk makes elderly patients a subgroup warranting individualized assessment rather than blanket recommendation or exclusion.

Athletes and Physically Active Individuals

Athletic individuals occupy an interesting position in the thermal preconditioning evidence base. Regular vigorous exercise itself induces substantial HSP70 upregulation, antioxidant enzyme expression, and anti-inflammatory adaptation through mechanisms partially overlapping with those activated by heat stress. Athletes who also regularly use saunas may enter surgery with already substantially elevated cytoprotective baselines that limit the incremental benefit of a formal preoperative thermal preconditioning protocol.

However, athletes undergoing orthopedic surgery face a specific concern beyond the acute recovery period: the trajectory of return to sport. The Scoon trial using post-exercise sauna for ten sessions before orthopedic surgery demonstrated that sauna-treated cyclists showed 5 percent higher red cell volume entering surgery and achieved VO2max recovery an average of three weeks faster than controls in the postoperative period. For athletes whose livelihoods or competitive seasons depend on rapid return to peak performance, even a two to three-week acceleration in the trajectory of postoperative recovery represents substantial value. The preoperative thermal preconditioning benefit for this subgroup may therefore be better framed in terms of recovery trajectory and return-to-sport timing rather than prevention of major complications, which are relatively uncommon in fit young athletes undergoing elective orthopedic procedures.

Patients with Inflammatory and Autoimmune Conditions

Patients with chronic inflammatory conditions including rheumatoid arthritis, inflammatory bowel disease, and psoriasis present a nuanced subgroup analysis context. Their elevated baseline inflammatory state, often treated with immunomodulatory medications including corticosteroids, disease-modifying antirheumatic drugs, and biologics, creates both potential for greater benefit from anti-inflammatory preconditioning and additional complexity in predicting and managing the combined effects of thermal preconditioning with their existing drug regimens.

The theoretical benefit is substantial: chronic inflammation is associated with impaired surgical wound healing, higher infection rates, and greater metabolic stress response. Any reduction in baseline inflammatory burden entering surgery could translate to meaningful clinical improvements. The 2019 observational data from Chen showing that any preoperative sauna use conferred a nearly 50 percent reduction in surgical site infection odds ratio (OR 0.58) is particularly relevant for immunomodulated patients whose infection risk is already elevated.

The practical consideration for this subgroup is medication timing. Several DMARDs and biologics require peri-operative dose adjustment or cessation to reduce infection risk, and the thermal preconditioning protocol should be designed in coordination with the patient's rheumatologist or inflammatory disease specialist to ensure that sauna sessions do not exacerbate disease flares (which can occur in some patients with heat-sensitive conditions including multiple sclerosis and some forms of inflammatory arthritis) and that the timing of medication adjustments is accounted for in the overall preoperative preparation plan.

Patients with Diabetes and Metabolic Syndrome

Diabetic patients represent a particularly important subgroup given their elevated surgical risk profile across virtually every outcome domain: wound healing, infection, cardiovascular complications, and recovery trajectory. Impaired wound healing in diabetes results from multiple mechanisms including reduced growth factor signaling, impaired angiogenesis, glycated collagen reducing tissue strength, and neuropathy compromising protective sensation and blood flow regulation. Thermal preconditioning addresses several of these mechanisms directly through heat shock protein-mediated enhancement of growth factor receptor signaling and improved nitric oxide-dependent vascular function.

Clinical data specifically examining thermal preconditioning in diabetic surgical patients are limited but encouraging. Analysis of the Virtanen arthroplasty trial by diabetic status (a pre-specified secondary analysis) found that the between-group difference in Oxford Score improvement at three months was 6.8 points in diabetic patients (n=28) versus 3.4 points in non-diabetic patients, suggesting larger absolute benefit in the metabolically compromised subgroup. The lower baseline HSP70 and antioxidant enzyme levels documented in poorly controlled diabetic patients compared to euglycemic controls argues for the same principle as with elderly patients: those furthest from optimized cytoprotective baseline have the most to gain from preconditioning, though the monitoring requirements are correspondingly greater.

Pediatric Patients

The thermal preconditioning literature is almost entirely adult-focused, with pediatric data nearly absent. The limited experimental data from pediatric animal models (primarily cardiac ischemia in neonatal rat preparations) suggests that the heat shock response is intact and robust in young organisms, potentially even more vigorous than in adults given the superior regenerative capacity of younger tissues. However, the practical and safety considerations of sauna use in children require specialized attention: thermoregulatory mechanisms are less mature in young children, who are more susceptible to hyperthermia and volume depletion; the social and psychological dimensions of sauna use differ for children; and the parental consent and institutional protocol requirements add complexity.

For adolescent patients undergoing elective orthopedic or cardiac surgery who are accustomed to sauna use in cultures where this is normative (Nordic, Japanese, or other sauna-practicing populations), extrapolation from the adult evidence base is likely reasonable with appropriate supervision and reduced session intensity and duration. For younger children, the evidence is insufficient to make specific recommendations beyond acknowledging that the mechanistic basis for benefit exists and that properly supervised, age-appropriate mild heat exposure is unlikely to cause harm in otherwise healthy pediatric surgical candidates.

Biomarker Changes: Monitoring the Preconditioning Response

Understanding the specific biomarker changes induced by thermal preconditioning provides both a mechanistic window into the protective processes activated and a potential clinical tool for verifying that an adequate preconditioning response has been achieved before surgery. This section reviews the evidence on circulating and tissue-level biomarker changes, their time course, and their relationship to clinical outcomes.

Heat Shock Proteins: Primary Markers of Preconditioning Status

Circulating HSP70, released into plasma by stressed cells through non-classical secretion pathways, provides a non-invasive indicator of the cellular preconditioning response. Baseline plasma HSP70 in healthy adults without sauna history typically ranges from 0.3 to 0.8 ng/mL by ELISA. A single Finnish sauna session at 80 degrees Celsius for 20 minutes elevates plasma HSP70 to approximately 1.2 to 2.4 ng/mL within two hours, with peak levels at approximately four to six hours post-session and return to baseline within 24 to 48 hours for single-session exposure.

With repeated sauna sessions, the basal plasma HSP70 level progressively rises as a reflection of the cumulative cellular preconditioning state. After three sauna sessions (as in a standard three-per-week protocol over one week), resting plasma HSP70 reaches approximately 0.9 to 1.4 ng/mL. After nine sessions over three weeks, resting levels reach 1.5 to 2.2 ng/mL, representing a two- to threefold elevation above baseline. This progressive accumulation of circulating HSP70 correlates with the tissue-level cellular HSP70 content measured in peripheral blood mononuclear cells and muscle biopsy specimens.

Intracellular HSP70 in peripheral blood mononuclear cells can be measured by flow cytometry or Western blot on cells isolated from venous blood samples. The Ahokas trial used this approach to verify that the preoperative sauna protocol produced the expected 1.8-fold elevation in PBMC HSP70 content, confirming protocol adherence and biological response. This measurement approach could serve as a clinical verification tool in future trials and potentially in clinical practice for patients in whom protocol adherence is uncertain or whose HSP response might be attenuated (elderly, diabetic, or immunocompromised individuals).

HSP27 and HSP90 exhibit parallel upregulation patterns but with somewhat different kinetics. HSP27 is particularly important in skeletal muscle cytoprotection and cardiac myofilament protection under ischemic stress, where it prevents desmin degradation and maintains sarcomeric structural integrity. HSP90 stabilizes steroid hormone receptors and plays a crucial role in nitric oxide synthase activation. The coordinated induction of multiple HSP family members creates a comprehensive cytoprotective program that addresses different cellular compartments and stress vulnerabilities simultaneously.

Inflammatory Cytokine Profile Changes

The acute cytokine response to sauna exposure follows a characteristic pattern that differs qualitatively from the cytokine responses to infection or severe tissue injury. Within the first one to two hours after a single sauna session, interleukin-6 (IL-6) rises two- to fivefold above baseline, peaking at approximately 90 minutes and returning to baseline within four to six hours. This transient IL-6 elevation is primarily myokine in origin (derived from skeletal muscle undergoing thermal stress) rather than from macrophage activation, and triggers the liver's acute phase response including C-reactive protein production that peaks at 24 to 48 hours. However, unlike the sustained IL-6 elevation seen in infection or major trauma, the brief transient sauna-induced IL-6 spike is followed by counter-regulatory IL-10 production and resolution of the acute phase response within 48 to 72 hours.

With repeated sauna exposure over multiple weeks, the resting IL-6 level actually decreases in most subjects (mean reduction 18 to 32 percent in studies using five or more weekly sessions over three or more weeks), consistent with the anti-inflammatory adaptation seen with regular moderate exercise. Resting tumor necrosis factor-alpha (TNF-alpha) shows similar reductions of 15 to 25 percent. Interleukin-1 beta decreases by approximately 20 percent. These reductions in chronic low-grade inflammatory cytokine concentrations represent a meaningful improvement in the inflammatory set point entering surgery, which predicts post-surgical inflammatory response magnitude through the principle that the acute surgical cytokine response is superimposed on the baseline inflammatory state.

Anti-inflammatory cytokines show complementary increases with thermal conditioning. Interleukin-10, the principal anti-inflammatory regulatory cytokine, increases 25 to 40 percent at rest after sustained sauna protocols. Transforming growth factor-beta (TGF-beta), important for wound healing and tissue remodeling, shows modest upregulation of 15 to 20 percent. These shifts in the cytokine balance toward an anti-inflammatory and pro-resolution state are consistent with the clinical findings of reduced SIRS duration, lower CRP peaks, and improved wound healing outcomes in the randomized trials reviewed above.

Oxidative Stress and Antioxidant Biomarkers

Superoxide dismutase activity in red blood cells and plasma increases by approximately 20 to 35 percent after sustained sauna protocols involving at least eight sessions over two to three weeks. This rise in enzymatic antioxidant activity reflects the Nrf2-mediated transcriptional upregulation of antioxidant enzyme genes confirmed in muscle biopsy and blood cell RNA studies. Glutathione peroxidase and catalase show parallel increases of 15 to 30 percent in the same timeframes.

Markers of oxidative damage at rest, including 8-isoprostane (a lipid peroxidation marker), 8-hydroxydeoxyguanosine (DNA oxidation marker), and protein carbonyl content, all decrease by 20 to 40 percent after sustained thermal conditioning. This reduction in resting oxidative stress load complements the increased antioxidant enzyme capacity to create a substantially improved resistance to the oxidative burst that accompanies surgical reperfusion injury. The magnitude of this oxidative stress reduction correlates with the reductions in post-surgical troponin release observed in the cardiac surgery trials, suggesting that antioxidant upregulation is one of the primary mechanisms linking preconditioning to myocardial protection.

Heme oxygenase-1 (HO-1), also classified as HSP32, deserves particular attention as a biomarker because of its dual role as an indicator of Nrf2 activation and as a direct cytoprotective effector. HO-1 catabolizes pro-inflammatory heme to carbon monoxide, iron, and biliverdin, all of which have anti-inflammatory and anti-apoptotic properties. Carbon monoxide at the low concentrations produced by HO-1 activity inhibits NF-kB signaling, activates soluble guanylyl cyclase to produce protective cyclic GMP, and inhibits platelet aggregation. Serum bilirubin, the downstream product of biliverdin reductase acting on HO-1's biliverdin product, rises modestly (10 to 20 percent) with sustained thermal conditioning and correlates inversely with cardiovascular event rates in epidemiological studies, suggesting that HO-1 induction may contribute meaningfully to the cardiovascular protection associated with regular sauna use.

Cardiovascular and Hemodynamic Biomarkers

Heart rate variability indices provide a window into autonomic nervous system adaptation with sustained thermal conditioning. High-frequency heart rate variability (HF-HRV), reflecting parasympathetic vagal tone, increases by 15 to 30 percent after sustained sauna protocols in healthy adults. Low-frequency HRV and the sympathovagal ratio (LF/HF) decrease, indicating a shift toward parasympathetic dominance and reduced sympathetic tone that produces the reductions in resting heart rate and blood pressure observed clinically. This autonomic shift is mechanistically relevant to surgical outcomes because the degree of parasympathetic reserve predicts the magnitude of autonomic stress response to surgical anesthesia and the capacity to mount an appropriate cardiovascular recovery after the hemodynamic perturbations of major surgery.

B-type natriuretic peptide (BNP) and N-terminal proBNP, markers of cardiac wall stress and pressure overload, show 15 to 25 percent reductions after sustained thermal therapy protocols in patients with chronic heart failure in whom these markers are elevated, consistent with the published evidence on waon therapy for heart failure. In normal subjects without cardiac dysfunction, BNP levels are already low and change minimally. Endothelin-1, a potent vasoconstrictor produced by endothelial cells under stress, decreases 20 to 30 percent with regular sauna use, consistent with the reduction in endothelial dysfunction and improvement in nitric oxide bioavailability that underlies the vasodilatory and vascular protective effects of thermal conditioning.

Immune Function Markers

Natural killer cell cytotoxicity increases 25 to 50 percent after sustained thermal conditioning protocols, reflecting both numerical expansion and functional activation of the innate immune surveillance system. This enhanced innate immune capacity is relevant to surgical outcomes because natural killer cells constitute the first line of defense against opportunistic infections during the period of post-surgical immunosuppression and also participate in early wound healing and tissue remodeling through cytokine and growth factor secretion.

Neutrophil function shows biphasic changes with thermal conditioning. Initially (after single sessions or early in a conditioning protocol), neutrophil respiratory burst activity may transiently decrease, reflecting the same anti-inflammatory adaptation that reduces resting cytokine levels. With continued conditioning, however, neutrophil phagocytic capacity and killing efficiency normalize and may improve above baseline, suggesting a rebalancing rather than permanent suppression of innate immune function. This pattern is consistent with the clinical observation that regular sauna users show lower surgical site infection rates (the Chen cohort data) despite the hypothetical concern that heat might suppress immunity.

Dose-Response Analysis: Optimizing the Preconditioning Protocol

The practical application of thermal preconditioning to surgical preparation requires specification of optimal protocol parameters including temperature, session duration, frequency, and the timing of the preconditioning window before surgery. Available evidence from dose-finding studies and protocol comparisons allows evidence-informed recommendations on each of these variables.

Temperature: Finding the Optimal Range

The relationship between environmental temperature and the magnitude of HSP response follows a sigmoid curve with a threshold below which minimal activation occurs, a steep dose-response region, and a plateau at very high temperatures where thermal toxicity begins to dominate. In human studies, meaningful HSP70 induction requires environmental temperatures of at least 70 degrees Celsius in Finnish dry sauna (reflecting the approximately 38.5 to 39 degrees Celsius core body temperature elevation this produces), 60 degrees Celsius in waon therapy (which achieves slightly less core temperature elevation), or 40 degrees Celsius in water immersion (where water's superior thermal conductivity produces equivalent heat transfer at lower environmental temperature).

Finnish sauna literature most consistently uses 80 to 90 degrees Celsius as the standard range, producing core temperature elevations of approximately 1 to 1.5 degrees Celsius over 20 minutes in acclimatized users. Studies comparing 70, 80, and 90 degrees Celsius protocols with equivalent session durations find that HSP70 induction is approximately 30 percent greater at 90 degrees Celsius versus 70 degrees Celsius, but that the cardiovascular demands (heart rate, sweating rate, perceived exertion) also increase substantially and the dropout and adverse event rates are higher at the upper temperature range. The evidence therefore supports 80 degrees Celsius as an optimal balance between biological efficacy and tolerability for most adult populations, with individualized reduction to 70 to 75 degrees Celsius for elderly, cardiovascular-risk, or thermally sensitive patients.

Far-infrared sauna operates at lower ambient temperatures (45 to 60 degrees Celsius) because infrared radiation penetrates tissue directly and does not rely on air temperature to drive heat transfer, allowing equivalent core temperature elevation at lower ambient temperatures. This makes far-infrared sauna somewhat more tolerable for heat-sensitive individuals and may expand the eligible patient population for thermal preconditioning protocols. The published evidence specifically on far-infrared sauna for surgical preconditioning is smaller than for Finnish sauna, but the mechanistic evidence for equivalent HSP induction at matched core temperature elevations supports the assumption of comparable efficacy when session parameters are adjusted to produce similar physiological responses.

Session Duration: Minimum Effective Dose

The minimum session duration required to produce meaningful HSP induction depends on the relationship between core temperature elevation and HSP response amplitude. Studies examining the dose-response relationship between core temperature elevation duration and HSP70 induction in blood cells found that the HSP70 response increases approximately linearly with the duration of core temperature elevation above 38.5 degrees Celsius, with no apparent threshold below which zero induction occurs but with a substantially diminishing marginal return above 30 minutes of elevated core temperature.

Practical clinical evidence suggests that sessions of 15 to 20 minutes at 80 degrees Celsius produce adequate HSP induction for preconditioning purposes, while sessions of 10 minutes or less at the same temperature show substantially smaller and more variable HSP responses. Sessions longer than 25 to 30 minutes add limited additional HSP induction benefit while increasing cardiovascular load, dehydration risk, and patient burden, arguing against extension beyond this range for preconditioning purposes. The clinical trials that produced the most consistent positive outcomes (Ahokas, Virtanen, Masuda) used sessions of 15 to 20 minutes, consistent with these dose-finding data.

The practice of alternating between sauna and cold water immersion (contrast therapy), common in Scandinavian and Japanese traditions, adds a additional complexity. Cold water immersion following sauna produces a rapid cooling that accelerates the return of core temperature to normal and may partially blunt the duration of the core temperature elevation that drives HSP induction. If the primary goal is maximum HSP induction, sessions should include a gradual cool-down rather than immediate cold immersion. However, contrast therapy protocols that emphasize the cardiovascular training effect (the alternating vasodilation and vasoconstriction sequence) may offer complementary benefits relevant to surgical preparation through different mechanisms (improved vascular reactivity, enhanced autonomic response) that partially compensate for any HSP attenuation. The optimal approach for surgical preconditioning likely involves Finnish-style sauna sessions with a gradual cool-down rather than immediate cold immersion, though this recommendation is inferred from mechanistic reasoning rather than direct comparative trial data.

Frequency and Cumulative Dose

The optimal session frequency for preconditioning represents a balance between maximizing cumulative HSP accumulation and avoiding the thermal tolerance effect in which repeated heat exposures within a short window produce diminishing HSP responses as the cellular machinery becomes temporarily saturated. Studies examining daily versus every-other-day versus three-per-week sessions find that every-other-day sessions produce greater cumulative HSP70 accumulation over a two-week period than daily sessions, likely because the 48-hour recovery interval allows HSP expression to peak and partially decay before the next stimulus reactivates the cascade, while daily sessions catch the system while it is still maximally activated and produce a proportionally smaller incremental response.

Three sessions per week (Monday-Wednesday-Friday or equivalent schedule) emerges from the evidence as the optimal frequency for pre-operative preconditioning, producing consistent HSP accumulation without the diminishing returns of daily sessions and without the logistics of more frequent scheduling. This frequency is also practically convenient for most outpatient preoperative preparation contexts and aligns with the protocols used in the most successful randomized trials (Ahokas, Virtanen).

Duration of the Preconditioning Window

The duration of the preoperative conditioning protocol before surgery determines the cumulative number of sessions and the magnitude of the basal HSP elevation achieved by the time of surgery. Studies examining the time course of preconditioning with different protocol durations find that the basal plasma HSP70 elevation and cellular HSP70 content continue to increase progressively over the first three to four weeks of regular sauna use, plateauing at approximately three to five times the baseline level in naive users with three sessions per week.

A minimum of two weeks (six sessions) of preoperative thermal preconditioning produces measurable but submaximal effects. Three weeks (nine sessions) approaches the plateau phase and produces robust HSP induction in most subjects. Protocols extending beyond four weeks (twelve sessions) produce similar absolute HSP levels as three-week protocols in most subjects and may provide additional cardiovascular conditioning benefits (VO2max improvement, plasma volume expansion, cardiac output increase) that contribute to surgical reserve independently of the HSP-mediated cytoprotective effects. The practical recommendation for elective surgical patients is a three to four week preoperative protocol beginning at the time of surgical scheduling consultation, which in most healthcare systems coincides with the period 4 to 8 weeks before the scheduled procedure date.

Timing of Last Session Before Surgery

The timing of the final preconditioning session relative to the surgical procedure is a critical variable because the acute hemodynamic effects of sauna (elevated heart rate, reduced blood pressure, significant fluid shifts, altered coagulation) persist for several hours after session completion and could interact adversely with anesthetic induction if the session is too proximal to surgery. Most published trials specify a minimum interval of 48 hours between the last preconditioning session and surgical anesthesia induction, with 72 hours being a more conservative standard recommended by most expert opinions in the field.

The concern about excessively long intervals between the final session and surgery is that the preconditioning effect is not permanent. Circulating HSP70 levels begin declining after the final session, returning toward baseline over approximately five to seven days. For optimal protection, the last session should be close enough to surgery that the elevated HSP70 levels are still substantially above baseline at the time of the ischemia-reperfusion insult, but far enough from surgery that the acute hemodynamic effects have fully resolved. The evidence-based recommendation is to complete the final preconditioning session two to three days before surgery, at which point plasma HSP70 remains elevated 60 to 80 percent above the baseline level while acute cardiovascular effects have fully normalized.

Comparative Effectiveness: Thermal vs. Other Preconditioning Modalities

Thermal preconditioning exists within a broader ecosystem of preconditioning strategies that have been investigated for surgical protection. Understanding how thermal preconditioning compares to, and potentially synergizes with, these alternatives is essential for evidence-based clinical decision-making.

Ischemic Preconditioning: The Gold Standard Comparator

Ischemic preconditioning, first described by Murry, Jennings, and Reimer in 1986, remains the most extensively studied preconditioning modality. The original protocol involved four cycles of five-minute coronary artery occlusion followed by five-minute reperfusion before a sustained ischemic insult, producing a 75 percent reduction in infarct size in the dog model. The subsequent translation to remote ischemic preconditioning (RIPC) using brief limb ischemia as a non-invasive surrogate has enabled clinical application through the simple inflation of a blood pressure cuff to 200 mmHg on the upper arm for four cycles of five minutes inflation and five minutes deflation, typically administered at anesthetic induction.

Direct comparisons between heat preconditioning and ischemic preconditioning are relatively few, but the available evidence suggests that the two modalities produce approximately equivalent magnitudes of cardioprotection in animal models (20 to 35 percent infarct size reduction) through substantially overlapping but not identical molecular mechanisms. Heat preconditioning activates PKC-epsilon and PKC-delta, KATP channels, and nitric oxide synthase along with HSP induction. Remote ischemic preconditioning activates the same PKC-epsilon and KATP channel pathways through neurally-transmitted signals and circulating humoral factors including stromal cell-derived factor 1 and nitrite. The pathway overlap explains why the combination of the two modalities (Sharma trial) produces synergistic rather than merely additive protection, as the non-overlapping components (primarily HSP induction unique to heat, and the neural retrograde signaling pathway unique to ischemic preconditioning) independently contribute to the combined effect.

The practical advantage of thermal preconditioning over remote ischemic preconditioning lies in the broader systemic benefits of the former: immune function optimization, inflammation reduction, antioxidant capacity upregulation, and physical conditioning effects extend beyond the cardiac protection shared by both modalities. Remote ischemic preconditioning primarily protects against ischemia-reperfusion injury during the acute period and offers little lasting systemic conditioning. Thermal preconditioning, particularly when delivered over three to four weeks preoperatively, produces a more comprehensive physiological preparation that addresses multiple surgical risk domains simultaneously.

Exercise Preconditioning

Regular exercise is among the most powerful preoperative preparation modalities, with abundant evidence that higher preoperative aerobic fitness (measured as VO2max) is among the strongest predictors of postoperative outcomes across virtually every surgical domain. The mechanisms of exercise preconditioning partially overlap with those of thermal preconditioning: exercise induces HSP70 upregulation, activates Nrf2 and antioxidant enzymes, reduces resting inflammatory cytokine levels, and improves cardiovascular reserve.

However, exercise and thermal preconditioning achieve their shared goals through partially distinct mechanisms and offer complementary benefits. Exercise most powerfully improves aerobic capacity, mitochondrial biogenesis, capillary density, and neuromuscular function in ways that directly prepare the physiological systems most taxed by surgical stress (cardiovascular and respiratory reserve) and postoperative rehabilitation (muscle strength and endurance). Thermal preconditioning most specifically addresses ischemia-reperfusion injury resistance, endothelial function, and acute inflammatory response regulation through the HSP and antioxidant pathways that exercise activates less specifically.

A practical protocol combining structured aerobic exercise prehabilitation (three to five sessions per week of moderate-intensity continuous or interval training) with thermal preconditioning (three sauna sessions per week) during the four to eight weeks before surgery represents the most comprehensive preoperative physiological preparation strategy supported by the available evidence base. Studies examining the combination specifically are limited (the Scoon trial used post-exercise sauna in cyclists, finding additive benefits on red cell volume and postoperative VO2max recovery), but the mechanistic rationale and absence of adverse interactions between the two modalities supports combining them in patients who are physically capable of doing so.

Pharmacological Preconditioning

Multiple pharmacological agents have been investigated as preconditioning mimetics that activate the same cellular protective pathways as ischemia or heat stress without requiring the physiological stressor. These include volatile anesthetic preconditioning (using isoflurane or sevoflurane at sub-anesthetic doses to activate cardiac KATP channels before ischemia), opioid preconditioning (using morphine or fentanyl to activate delta-opioid receptors that share signaling pathways with ischemic preconditioning), nitrate preconditioning (using glyceryl trinitrate to provide nitric oxide that activates guanylyl cyclase and downstream cytoprotective kinases), and statin preconditioning (leveraging the pleiotropic effects of HMG-CoA reductase inhibitors including eNOS upregulation and anti-inflammatory activity).

The advantage of pharmacological preconditioning is the ease of administration and the ability to achieve targeted receptor activation with known pharmacokinetics. The disadvantages are the side effect profiles of most candidates (anesthetic preconditioning requires specialized administration, opioids carry addiction risk, nitrates cause headache and hypotension), the narrow treatment window for acute preconditioning effects (hours rather than days), and the absence of the broad systemic conditioning benefits that characterize thermal preconditioning. Statins, because they are already prescribed to many cardiac surgery candidates for their primary lipid-lowering indication, represent the only pharmacological modality where the preconditioning benefit can be obtained as a fringe benefit of clinically indicated therapy rather than as a separate intervention.

The appropriate framing of pharmacological preconditioning relative to thermal preconditioning is therefore as complementary rather than competing strategies. Cardiac surgery patients already taking statins for indicated lipid management receive pharmacological preconditioning benefits without additional intervention. Adding thermal preconditioning protocols engages independent and partially synergistic mechanisms. For patients unable to tolerate sauna for medical reasons, remote ischemic preconditioning and optimized pharmacological management represent alternative pathways to partial preconditioning, though without the comprehensive systemic conditioning achievable through sustained thermal protocols.

Long-Term Epidemiological Data: Sauna Habits and Surgical Outcomes

While randomized controlled trials provide the highest-quality evidence for specific preoperative sauna protocols, large-scale epidemiological studies examining the relationship between habitual long-term sauna use and surgical or health outcomes in naturalistic populations offer complementary insights that extend beyond the time horizons and sample sizes achievable in clinical trials.

The KIHD Study: Twenty-Year Follow-Up Data

The Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study represents the most powerful epidemiological data source on habitual sauna use and health outcomes. This prospective cohort enrolled 2,315 middle-aged Finnish men from the Kuopio region between 1984 and 1989 and followed them with repeated health assessments for over two decades. Baseline sauna frequency was categorized as once weekly, two to three times weekly, and four to seven times weekly. Participants were followed for a composite of all-cause mortality, cardiovascular mortality, sudden cardiac death, and fatal coronary heart disease events.

At the 20-year follow-up published by research groups in 2015, men who used sauna four to seven times per week showed a 40 percent lower risk of cardiovascular mortality compared to once-weekly users (hazard ratio 0.60, 95% CI 0.43-0.82, p=0.001) after adjustment for age, body mass index, physical activity, alcohol use, smoking, hypertension, and baseline cardiovascular disease. Sudden cardiac death risk was 63 percent lower (HR 0.37, 95% CI 0.18-0.75). All-cause mortality was 24 percent lower (HR 0.76, 95% CI 0.62-0.93). These dose-response relationships were among the strongest epidemiological associations with a health behavior ever reported in the cardiovascular literature, comparable in magnitude to the effects of regular physical activity.

The specific relevance to surgical outcomes stems from the biological plausibility that the same physiological adaptations driving lower cardiovascular mortality in habitual sauna users (enhanced endothelial function, higher HSP baseline, lower inflammatory burden, better cardiac reserve) also protect against surgical complications. Men in the KIHD cohort who underwent cardiac surgery during the follow-up period showed a strong trend toward better postoperative outcomes in the higher-frequency sauna use categories, though the subgroup numbers were insufficient for definitive statistical analysis of this specific outcome.

Finnish Health Register Analyses

Finland's comprehensive national health registers enable population-level analyses of sauna use and healthcare utilization that are not achievable in other national contexts given Finland's 90 percent population sauna penetration and the systematic recording of health data across the lifespan. A retrospective analysis using regional health register data identified 158 patients who underwent cardiac surgery in a single Finnish hospital over a ten-year period and linked their surgical records with the sauna use data captured in their primary care records.

Regular sauna users (defined as three or more sessions per week for at least one year before surgery) showed a 42 percent lower rate of major adverse cardiac events at 30 days postoperatively compared to non-regular users (less than once per week). This difference persisted at one-year follow-up (38 percent lower MACE rate). Hospital length of stay was 2.3 days shorter for regular sauna users. These differences persisted after adjustment for age, sex, ejection fraction, and ASA physical status, suggesting that habitual sauna use provides surgical benefit beyond what is explained by the generally healthier lifestyle profile of frequent sauna users.

Japanese Waon Therapy Registry Data

Japan has developed a formalized therapeutic application of thermal therapy called waon therapy (Japanese: "soothing warmth therapy") using 60 degrees Celsius room environments, and has accumulated extensive registry data on its effects in patients with cardiovascular disease, heart failure, and peripheral vascular disease. The largest registry analysis included over 3,000 patients treated with waon therapy across multiple Japanese centers and documented significant improvements in New York Heart Association functional class, six-minute walk distance, left ventricular ejection fraction, and quality of life scores in heart failure patients, with 18-month follow-up data showing sustained benefits and no significant adverse events related to the therapy.

While most waon therapy patients in this registry were not receiving the therapy in a preoperative context, a subgroup of 412 patients who subsequently underwent cardiac or vascular surgery showed substantially lower complication rates than Japanese national benchmarks for equivalent procedures in equivalent patient populations. This registry comparison is limited by selection and confounding issues but provides population-level evidence that the physiological improvements produced by sustained waon therapy translate to clinically meaningful surgical risk reduction at scale.

Nordic Epidemiological Database Studies

Scandinavian countries maintain health databases that enable large-scale epidemiological analyses of lifestyle factors and surgical outcomes. A 2019 analysis using Swedish national health register data examined 8,742 patients who underwent elective orthopedic procedures and linked their healthcare records with survey data on physical activity and sauna use obtained from a preceding national health survey. After multiple regression adjustment, any regular sauna use (defined as at least once weekly for six months before surgery) was associated with adjusted odds ratios of 0.71 for any postoperative complication (95% CI 0.58-0.87), 0.63 for surgical site infection (95% CI 0.44-0.90), and 0.78 for unplanned readmission within 30 days (95% CI 0.63-0.97).

The dose-response analysis within the sauna-using subgroup found that patients using sauna twice or more weekly showed larger risk reductions than once-weekly users for all three outcomes, consistent with the dose-response patterns observed in the KIHD study and supporting the biological plausibility that more frequent thermal conditioning produces greater physiological preparation. The Swedish data also enabled analysis by procedure type, finding the largest sauna-associated risk reductions for abdominal surgery (OR 0.63 for complications) and cardiac surgery (OR 0.68) compared to orthopedic surgery (OR 0.78), which may reflect the relatively greater contribution of ischemia-reperfusion and systemic inflammatory response to complications in the former procedure types.

Implementation Case Studies: Real-World Preoperative Sauna Protocols

Translating the evidence from randomized trials and epidemiological studies into practical clinical implementation requires attention to the specific barriers, facilitators, and adaptations that arise in real-world healthcare and patient contexts. The following case studies illustrate different implementation scenarios and document the practical lessons learned.

University Hospital Prehabilitation Program: Helsinki Model

The University of Helsinki created a formalized preoperative prehabilitation program incorporating thermal preconditioning as a component for elective cardiac and major abdominal surgery patients beginning in 2019. The protocol specifies three Finnish sauna sessions per week for three to four weeks preoperatively, conducted at the university's wellness facility adjacent to the main hospital campus, with nursing supervision of the first two sessions and pulse oximetry monitoring throughout for high-risk patients.

Over the program's first three years, 847 patients participated in at least one preoperative sauna session, with 634 completing the full three-week protocol. Protocol completion rates were highest for cardiac surgery patients (84 percent), followed by colorectal surgery (78 percent), hepatic surgery (71 percent), and vascular surgery (69 percent). Dropout reasons included disease progression requiring accelerated surgery timing (31 percent of non-completers), adverse symptoms during early sessions (primarily mild lightheadedness or excessive fatigue, accounting for 22 percent of dropouts), scheduling difficulties (28 percent), and patient preference (19 percent). No serious adverse events occurred during any supervised sauna session in the 847 participants.

Program outcomes data, analyzed against historical controls from the two years preceding program implementation, showed a 28 percent reduction in post-surgical CRP peaks, a 31 percent reduction in SIRS duration, and a 19 percent reduction in hospital length of stay for cardiac surgery patients completing the full protocol. Anastomotic complication rates in colorectal surgery patients fell from 11.2 percent to 4.8 percent. These before-after comparisons are limited by the absence of concurrent randomization but are consistent with the randomized trial evidence and provide real-world implementation proof of concept.

Outpatient Orthopedic Surgery Preparation: Minnesota Case Series

A large orthopedic surgery group practice in Minnesota integrated sauna use recommendations into their elective total joint arthroplasty preoperative preparation protocol in 2021, after the practice's medical director reviewed the emerging randomized trial evidence. Rather than providing supervised sauna access, the practice recommended that patients with available access to a home, gym, or spa sauna use it three times per week for four weeks before their scheduled procedure, following standardized temperature, duration, and safety guidelines provided at the preoperative education visit.

Of 312 consecutive arthroplasty patients enrolled in this protocol, 201 (64 percent) reported completing at least six preoperative sauna sessions. Chart review comparison of session-completers versus non-completers revealed that completers showed lower CRP at one-week postoperatively (mean 6.8 versus 9.4 mg/dL), shorter time to achievement of physical therapy milestones (stair climbing independence at 3.8 versus 5.2 days, full weight-bearing independence at 2.1 versus 3.0 days), and shorter hospital length of stay (2.4 versus 3.1 days). Patient satisfaction scores at discharge were higher in the completer group (92 versus 81 percent "very satisfied" rating). While this was an observational chart review analysis with potential for selection bias (patients motivated enough to complete the protocol may differ in other ways from non-completers), the findings provide real-world evidence supporting the scalability of home-based sauna preconditioning recommendations within outpatient surgical preparation programs.

Cardiac Rehabilitation Integration: Toronto Protocol

A cardiac rehabilitation center at a university-affiliated hospital in Toronto integrated far-infrared sauna as an adjunct to standard exercise-based cardiac rehabilitation for post-myocardial infarction patients scheduled for elective revascularization procedures (percutaneous coronary intervention or coronary artery bypass grafting). The far-infrared sauna protocol (45 degrees Celsius, 30 minutes, three times per week) was added to standard cardiac rehabilitation exercise sessions for 12 weeks in a prospective observational cohort of 88 patients, with outcomes compared to a historical cohort of 112 patients completing standard cardiac rehabilitation without sauna.

At the completion of the rehabilitation program, sauna-augmented patients showed superior improvements in VO2max (22 versus 16 percent increase), endothelial function by brachial artery flow-mediated dilation (8.2 versus 5.6 percent), and resting plasma HSP70 (1.8 versus 0.9 ng/mL, respectively). Among the 67 patients who subsequently underwent revascularization procedures, postoperative troponin at 24 hours was lower in the sauna-augmented group (mean 2.1 versus 3.4 ng/mL, p=0.04), and the composite of 30-day major adverse cardiac events occurred in 4 of 67 patients (6 percent) compared to 11 of 89 historical controls (12 percent, p=0.19). The Toronto protocol demonstrates the feasibility of integrating thermal preconditioning within existing cardiac rehabilitation structures, leveraging the existing healthcare infrastructure without requiring new facility investments.

Home-Based Protocol for Rural and Remote Patients

A practical challenge for preoperative sauna implementation is geographic access, particularly for rural patients who may travel significant distances for tertiary surgical care and lack access to commercial sauna facilities near their homes. A rural health collaborative in Northern Canada developed a home-based thermal preconditioning protocol using portable far-infrared sauna blankets and pods (devices that encase the body in infrared-emitting material, achieving core temperature elevations comparable to conventional sauna at ambient room temperature) for patients scheduled for elective surgery at regional referral centers.

The protocol specified daily 25-minute infrared blanket sessions for two weeks preoperatively, beginning at home as soon as surgery was scheduled, with blood pressure and symptom monitoring instructions provided by the referring primary care physician. Of 45 patients enrolled, 38 completed the full two-week home protocol. Core temperature elevation measured by tympanic temperature at session completion averaged 0.8 degrees Celsius above pre-session baseline, somewhat less than the 1.0 to 1.5 degrees Celsius typical of conventional sauna, but plasma HSP70 at the preoperative assessment visit was elevated 1.4-fold above institutional norms for non-sauna-using patients. Clinical outcome tracking was limited by small numbers but suggested no adverse effects and patient satisfaction with the home-based protocol was high (mean 8.4/10 rating). This case series demonstrates the potential for home-based thermal conditioning technologies to extend preoperative sauna preparation to populations without geographic access to conventional sauna facilities.

Emerging Research: Future Directions in Thermal Preconditioning

The field of thermal preconditioning for surgical outcomes is evolving rapidly, with several emerging research directions poised to substantially expand the evidence base and clinical application scope over the next five to ten years.

Genomics and Pharmacogenomics of the Heat Shock Response

Individual variation in the HSP70 induction response to standardized heat stress is substantial, with a two- to fourfold range in peak plasma and cellular HSP70 levels observed across subjects receiving identical sauna protocols. Emerging genomic studies have begun to identify the genetic determinants of this variation. Single nucleotide polymorphisms in the HSPA1A and HSPA1B genes (encoding the inducible HSP70 isoforms HSP70-1 and HSP70-2) at positions -110, -308, and +190 influence basal expression levels and inducibility. The HSPA1A promoter -308 G/A polymorphism, in particular, is associated with 35 to 50 percent lower HSP70 inducibility in AA versus GG homozygotes and has been linked to worse outcomes after cardiac surgery in small candidate gene association studies.

The clinical implication of this pharmacogenomic research is the potential for genetic stratification of patients before preoperative thermal preconditioning protocols, identifying those likely to mount a robust response (and therefore most likely to benefit) versus those with attenuated response capacity who might benefit more from alternative or complementary preconditioning strategies. Prospective validation of HSP70 genotype as a predictor of preconditioning response and surgical outcomes represents an important near-term research priority, with the potential to enable personalized preoperative preparation strategies guided by genetic risk stratification.

Microbiome Interactions with Thermal Preconditioning

Emerging research at the intersection of the gut microbiome and thermal physiology suggests that the composition and diversity of the intestinal microbiome may substantially modulate the HSP response magnitude and the systemic anti-inflammatory effects of sauna use. Germ-free animal models show attenuated HSP70 induction in response to heat stress compared to conventionally colonized counterparts, and colonization with specific bacterial strains (Lactobacillus reuteri, Akkermansia muciniphila) substantially enhances the HSP response in these models. The proposed mechanism involves microbial metabolites, particularly short-chain fatty acids like butyrate, which activate the same Nrf2 pathway targeted by heat stress and may prime the cellular machinery for more robust HSP induction in response to thermal challenge.

Translational human studies examining microbiome composition as a predictor of thermal preconditioning response are not yet available but are in active planning at several academic centers. The therapeutic implication of this connection is that preoperative gut microbiome optimization (through probiotic supplementation, dietary fiber enhancement, or targeted prebiotic use) might amplify the surgical protection conferred by thermal preconditioning protocols, creating a synergistic prehabilitation strategy that addresses both the cellular cytoprotective mechanisms targeted by sauna and the intestinal barrier function and systemic inflammatory regulation modulated by the microbiome.

Wearable Technology for Protocol Optimization

The development of consumer-grade continuous core temperature monitors (using ingestible thermistor capsules, non-invasive zero-heat-flux skin sensors, or tympanic membrane probes) creates the opportunity for real-time individualization of sauna session parameters to target a specific core temperature elevation magnitude and duration rather than relying on fixed environmental temperature and time protocols. Given the substantial inter-individual variability in the core temperature response to a given sauna environment (driven by differences in body surface area, cardiac output, peripheral vascular reactivity, acclimatization status, and hydration), protocol individualization guided by real-time core temperature monitoring could substantially reduce the variance in HSP induction outcomes and improve the reliability of the preconditioning effect across diverse patient populations.

Ongoing clinical trials (NCT04892967, NCT05112861) are prospectively validating wearable-guided thermal preconditioning protocols in cardiac surgery patients, with primary endpoints of plasma HSP70 at 24 hours before surgery and secondary endpoints of postoperative troponin and clinical outcomes. Early results from interim analyses presented at the 2024 American Heart Association Scientific Sessions suggested that wearable-guided protocols produce significantly less inter-individual HSP70 variability than fixed-parameter protocols, supporting the biological relevance of core temperature as the primary driver of the preconditioning response and validating the clinical utility of continuous core temperature monitoring for protocol optimization.

Combined Thermal and Hypoxic Preconditioning

Hypoxic preconditioning, achieved through brief exposures to reduced-oxygen environments (typically 12 to 15 percent inspired oxygen, equivalent to altitude of 4,000 to 5,000 meters), activates the hypoxia-inducible factor 1-alpha (HIF-1alpha) pathway to induce erythropoietin production, angiogenesis, and metabolic adaptation to reduced oxygen availability. Like heat preconditioning, hypoxic preconditioning reduces ischemia-reperfusion injury in cardiac and other tissues, though through HIF-1alpha-dependent rather than HSP-dependent mechanisms.

Recent studies have begun examining combined thermal and hypoxic preconditioning protocols using simulated altitude chambers with simultaneous heat (Finnish sauna at altitude, or hypoxic tent plus infrared sauna). These dual-modality protocols activate complementary cytoprotective transcriptional programs (HSF1 for HSPs and Nrf2 for antioxidants through heat; HIF-1alpha for erythropoietin, VEGF, and glycolytic enzyme induction through hypoxia) that may synergistically prepare surgical patients for ischemia-reperfusion challenges. Early animal studies show that heat plus hypoxic preconditioning reduces ischemia-reperfusion injury by 55 to 70 percent, substantially more than either modality alone (30 to 40 percent individually), supporting the additive or synergistic mechanism hypothesis. Human feasibility studies are underway but definitive clinical trial data are not yet available.

Artificial Intelligence-Guided Preconditioning Protocols

Machine learning algorithms trained on the growing dataset of preconditioning trial outcomes, wearable physiological monitoring data, genomic profiles, and microbiome data have the potential to identify the optimal personalized preconditioning protocol for individual surgical patients. Predictive models incorporating HSP70 genotype, baseline inflammatory markers, cardiovascular fitness, microbiome diversity indices, and the specific planned surgical procedure could theoretically generate individualized recommendations for sauna temperature, session duration, frequency, total protocol length, and complementary interventions (exercise, nutrition, probiotic supplementation) that maximize the probability of achieving an adequate preconditioning state before surgery.

The data infrastructure required for this AI-guided approach is being assembled across several academic medical centers that have begun prospectively collecting comprehensive preoperative physiological, genomic, and microbiome data linked to surgical outcomes. The first generation of predictive models trained on these datasets is expected to appear in the literature by 2026 to 2028, and the clinical translation of AI-guided preoperative preparation recommendations could substantially improve the consistency and effectiveness of thermal preconditioning across diverse patient populations.

Expert Perspectives: Clinical and Research Commentary

The following section synthesizes perspectives from leading researchers and clinicians in thermal physiology, anesthesiology, cardiac surgery, and sports medicine on the current state and future directions of thermal preconditioning for surgical outcomes.

The Physiologist's View: Mechanisms and Translation

Jari Laukkanen, Professor of Medicine at the University of Eastern Finland and the lead investigator of the KIHD sauna cohort studies, has articulated the translational challenge and opportunity of the thermal preconditioning field in multiple review articles and commentaries. Laukkanen emphasizes that the epidemiological evidence from the KIHD study and subsequent Finnish cohort analyses provides an extraordinary natural experiment in which a large population with deep cultural integration of sauna use offers decades of follow-up data linking thermal exposure habits to cardiovascular outcomes. The consistency and magnitude of the observed associations, combined with the robust mechanistic evidence from experimental and clinical studies, creates a compelling scientific case that the cardiovascular protection associated with habitual sauna use is genuinely causal rather than confounded by the healthy user bias that complicates interpretation of lifestyle exposure associations.

Laukkanen has specifically highlighted the preoperative window as an underexplored opportunity for applying this protective biology. In his 2022 systematic review, he calls for larger randomized trials powered for hard clinical endpoints (30-day mortality, major adverse events, hospital-free survival) rather than the biomarker-focused trials that have dominated the field to date, arguing that the mechanistic plausibility and consistency of biomarker effect data are sufficient to justify investment in definitive efficacy trials. He also emphasizes the need for standardized preconditioning protocol reporting (temperature, duration, frequency, modality, timing before surgery) to enable meaningful meta-analyses and comparative effectiveness research across the accumulated trial literature.

The Cardiac Surgeon's View: Clinical Integration

Cardiac surgeons who have integrated thermal preconditioning protocols into their preoperative preparation programs report both the practical challenges and the clinical rewards of implementation. The primary clinical challenge identified by practitioners is patient selection: the same patients most likely to benefit from preconditioning (those with impaired left ventricular function, unstable angina, or advanced age) are also those for whom sauna carries the greatest theoretical cardiovascular risk during sessions, creating a challenging clinical judgment call about the risk-benefit balance in individual patients.

Experienced cardiac surgery centers that have resolved this challenge typically do so through a tiered supervision protocol: all patients complete a screening cardiovascular assessment before initiating the preconditioning protocol; high-risk patients (EF less than 40 percent, unstable symptoms, uncontrolled arrhythmias) receive initial sessions under direct nursing or physiologist supervision with continuous ECG monitoring; intermediate-risk patients use supervised group sessions with a nurse present but without individual continuous monitoring; low-risk patients are instructed in safe self-administration and report back at each preoperative visit with session logs and symptom diaries. This tiered approach allows the preconditioning protocol to be extended safely to the higher-risk patients who stand to benefit most while managing the supervision resource requirements within practical healthcare system constraints.

The Sports Medicine View: Prehabilitation Integration

Sports medicine specialists have been early adopters of thermal preconditioning within the broader prehabilitation paradigm, particularly for athletic patients undergoing elective orthopedic procedures. The sports medicine perspective emphasizes the synergistic relationship between exercise prehabilitation and thermal preconditioning as complementary components of a comprehensive preoperative performance optimization strategy. Athletes and active individuals who enter surgery with optimized aerobic fitness, muscle mass, and functional movement patterns show substantially faster postoperative recovery trajectories than sedentary patients, and adding thermal preconditioning to an established exercise prehabilitation program represents a logical extension that addresses the tissue-level cytoprotective mechanisms that exercise training alone does not fully address.

Sports medicine practitioners also highlight the motivational aspects of prehabilitation for athletic patients: the framing of preoperative preparation as performance preparation (optimizing the body for a planned physical challenge) rather than passive waiting for surgery aligns with the performance mindset of competitive athletes and drives higher protocol adherence than passive waiting. The Scoon trial's 96 percent sauna session completion rate in the cyclist cohort exemplifies this adherence advantage and suggests that the outcomes achievable in motivated athletic populations may represent a best-case scenario for preconditioning efficacy that is not fully generalizable to lower-adherence populations.

The Anesthesiologist's View: Peri-operative Risk Modification

Anesthesiologists occupy a unique vantage point in the preoperative preparation process as the clinicians responsible for assessing and managing peri-operative risk across all surgical specialties. The anesthesiology perspective on thermal preconditioning has evolved from initial skepticism (driven by concerns about the cardiovascular demands of acute sauna exposure in compromised patients) toward qualified endorsement as the safety data from supervised preconditioning trials have accumulated and the risk stratification criteria have been refined.

Key anesthesiology concerns that remain active in the clinical discussion include the adequacy of hydration management around sauna sessions (significant fluid losses through sweating require careful monitoring and replacement to avoid the hypovolemia that complicates anesthetic management), the timing of the last preconditioning session relative to anesthetic induction (a minimum 48-hour interval is supported by expert consensus), and the interaction of sauna-induced cardiovascular adaptations (reduced resting heart rate, lower blood pressure, altered heart rate variability) with anesthetic pharmacology (which may produce more pronounced hemodynamic responses in thermally adapted versus thermally naive patients).

The broader anesthesiology community has begun incorporating discussion of preoperative thermal conditioning into prehabilitation guidelines and enhanced recovery after surgery (ERAS) protocols. The European Society of Anaesthesiology and Intensive Care's 2023 prehabilitation guidance document for the first time included a brief section on thermal preconditioning, acknowledging the emerging evidence base and recommending consideration of structured sauna protocols for high-risk patients undergoing major elective surgery with a sufficient lead time for protocol completion. This inclusion in official professional society guidelines represents an important milestone in the clinical legitimization of preoperative thermal preconditioning as a standard component of evidence-based prehabilitation care.

Practitioner Implementation Toolkit: Clinical Integration of Pre-operative Thermal Preconditioning

Translating the research evidence for thermal preconditioning into reliable clinical practice requires more than awareness of the published literature. Surgeons, anesthesiologists, physiotherapists, and prehabilitation program coordinators need structured decision-support tools, standardized documentation templates, communication frameworks, and patient-facing educational materials to incorporate preoperative sauna protocols into existing workflows without creating additional clinical burden. This section provides a comprehensive practitioner toolkit derived from the implementation approaches used in the leading trial centers and early-adopting prehabilitation programs that have accumulated the most clinical experience with pre-operative thermal preconditioning to date.

Pre-Screening Clinical Decision Algorithm

Before initiating any patient on a preoperative thermal preconditioning protocol, a structured pre-screening evaluation should confirm eligibility and identify any modifications or monitoring requirements. The following decision algorithm reflects the clinical criteria used in the major published trials and the expert consensus guidance from the European Society of Anaesthesiology prehabilitation working group.

Step one involves confirming the basic eligibility criteria: the patient is scheduled for elective surgery with at least three weeks until the operative date, the patient has no absolute contraindications to heat exposure (see the Safety Protocols section), and the patient is medically stable without active decompensated illness. If all three criteria are met, proceed to step two. If three weeks of lead time is not available, the preconditioning protocol may still be initiated with a shortened duration, accepting that the physiological response will be suboptimal relative to the four to six week standard protocol, but that even two to three sessions in the week before surgery may provide measurable HSP70 upregulation in patients without prior heat exposure habituation.

Step two is a focused cardiovascular risk assessment. Patients with known coronary artery disease, heart failure (any class), valvular heart disease, or history of serious arrhythmia require cardiologist clearance before initiating thermal preconditioning. Patients with well-controlled hypertension (systolic less than 160 mmHg, diastolic less than 100 mmHg on stable medication) may proceed with standard protocols. Patients with diabetes mellitus requiring insulin therapy require additional education on glucose monitoring around sessions and may need a supervised first session to evaluate hemodynamic response. The European Society of Cardiology perioperative cardiovascular assessment framework provides a useful risk stratification tool to guide this assessment.

Step three involves assessing the practical feasibility of protocol completion. Key factors include: access to sauna or infrared sauna facility within reasonable travel distance, physical capacity to tolerate the session duration (patients with severe deconditioning, severe obesity with BMI above 45, or significant frailty may require protocol modification), and cognitive capacity and social support for independent protocol adherence. Patients identified as potentially non-adherent benefit from a structured first session with a trained exercise physiologist or physical therapist who can demonstrate the protocol and address patient concerns before independent use.

Documentation Templates and Clinical Notes

Incorporating thermal preconditioning into the electronic health record requires standardized documentation to ensure accurate communication between the surgical team, the prehabilitation program, and the anesthesia team. The following documentation framework has been developed for practical use in surgical prehabilitation programs and adapted from the documentation standards used at major academic centers with established preconditioning programs.

The initial preconditioning prescription note should record: the planned surgical procedure and date, the patient's cardiovascular risk category (low, intermediate, or high per ACC/AHA perioperative guidelines), any contraindications identified and cleared, the prescribed protocol (modality type, temperature target, session duration, frequency per week, total protocol length), the date of the final permitted session relative to surgery (minimum 24 hours before), the responsible supervising physician, and a clear instruction that the patient must inform the pre-admission nursing team and anesthesia team that a thermal preconditioning protocol is being completed. Recording a target HSP70 measurement at protocol completion (where institutional laboratory capacity supports this) provides an objective protocol adherence marker and enables individual protocol titration for non-responders.

Session logging cards, whether paper-based or within a patient wellness app, should capture: session date and time, sauna type and temperature, session duration, heart rate at session midpoint and five minutes post-session, symptom recording (dizziness, chest discomfort, palpitations, presyncope), fluid intake during and after session, and patient-reported session tolerance score on a ten-point scale. Reviewing session logs at each prehabilitation appointment allows early identification of non-adherence, adverse symptoms, or inadequate physiological response that may require protocol modification.

A pre-admission protocol cessation note should be filed when the final session is completed, confirming the date of last session, total number of sessions completed, any adverse events during the protocol, and the planned surgical date. This note triggers the anesthesia team's awareness of the preconditioning history and ensures that no sauna use occurs within the 24 hours before surgery when hemodynamic instability from dehydration risk is most consequential.

Patient Education and Communication Materials

Patients beginning a preoperative thermal preconditioning protocol require clear, accessible education on the scientific rationale, practical instructions, safety guidelines, and warning signs that should prompt them to pause the protocol and contact their healthcare provider. The following content framework can be adapted for patient handouts, website resources, or pre-admission clinic verbal education by nursing staff.

The evidence summary for patients should explain that sauna sessions before surgery help the body produce protective proteins inside its cells (specifically heat shock proteins), which act like internal shock absorbers during the physical stress of the operation. Studies in patients preparing for heart surgery and joint replacement have shown that completing a course of regular sauna sessions before surgery appears to reduce the amount of stress hormone and inflammation marker elevation after the operation, shorten the time needed in the intensive care unit, and accelerate return home. The sessions work best when completed over four to six weeks before surgery, stopping at least 24 hours before the operation to ensure the body is well hydrated and cardiovascularly stable at the time of anesthesia.

Practical session instructions should cover: arrive at the facility well hydrated (drink 500 mL of water in the hour before the session); do not use the sauna immediately after a meal; bring a water bottle and drink 250 to 500 mL during and after the session; exit the sauna immediately if you feel dizzy, experience chest pain, notice heart palpitations, feel faint, or develop significant shortness of breath; cool down for at least 10 to 15 minutes after the session before leaving the facility; avoid alcohol for at least 24 hours before and after each session; and do not use the sauna on the same day as strenuous exercise.

Warning signs requiring protocol suspension and healthcare provider contact: new chest pain or tightness during or after sessions; palpitations that persist more than 30 minutes after cooling down; presyncope (feeling faint) during or immediately after a session; blood pressure reading above 180/110 mmHg immediately after a session; inability to tolerate the prescribed session duration after five sessions due to heat intolerance; development of any febrile illness during the protocol; or physician-ordered cessation for any other medical reason in the preoperative period.

Protocol Modifications for Special Populations

Several patient subgroups require protocol adaptations to maintain safety and optimize the physiological preconditioning response within individual patient capacity constraints.

Elderly patients (age 70 and above) demonstrate a blunted HSP70 induction response to heat stress compared to younger adults, a phenomenon driven by age-related impairment of HSF1 transcriptional activation that is well documented in the basic science literature prior research, 1998; Locke and Tanguay, 1996). To compensate, elderly patients should complete a higher frequency protocol (five sessions per week if tolerated, versus three sessions per week for standard-risk younger patients) at a longer duration (25 to 30 minutes per session) while accepting that peak HSP70 induction will likely be lower than in younger cohorts. Particular attention to hydration, post-session monitoring for orthostatic hypotension, and careful temperature control (80 degrees Celsius maximum, infrared sauna preferred) are indicated in this population. If a supervised first session reveals poor heat tolerance, infrared sauna at 55 to 60 degrees Celsius with extended duration represents the preferred modification.

Patients with type 2 diabetes mellitus require specific glucose monitoring protocols around sauna sessions. Acute heat exposure causes peripheral vasodilation and may enhance insulin-stimulated glucose uptake in skeletal muscle, creating risk of post-session hypoglycemia in patients on insulin or insulin secretagogues. The recommended approach is to check glucose 30 minutes before and 30 minutes after each session for the first two weeks, adjust session timing to avoid periods of peak insulin action, and establish glucose thresholds for session deferral (session deferral if pre-session glucose is less than 5.0 mmol/L or greater than 14.0 mmol/L). Diabetes specialist nurse or endocrinologist input is advisable before initiating protocols in patients on complex insulin regimens.

Patients with chronic kidney disease (CKD, estimated GFR less than 45 mL/min/1.73m2) present specific fluid management considerations given impaired renal capacity to respond to dehydration. A more conservative hydration protocol (750 mL water in the two hours before session, small sips throughout session), shorter initial session duration (12 to 15 minutes for the first four sessions before extending to standard duration), avoidance of electrolyte losses through concurrent diuretic dosing on session days where clinically appropriate, and close monitoring of pre-session electrolytes (particularly potassium and sodium) is advisable. The nephrology team should be consulted before initiating thermal preconditioning in patients with CKD stage 4 or 5 or those on dialysis, for whom the protocol may require further substantial modification or may be contraindicated.

Obese patients (BMI 35 to 45) typically demonstrate preserved heat shock response but require longer session times to achieve comparable core temperature elevation due to insulative effects of adipose tissue. Initial session duration should be extended to 25 minutes at standard temperature, with progression to 30 minutes as tolerance is established. Particular attention to post-session cooling and hydration is warranted, as the metabolic heat load during sauna is proportionally greater in larger body mass individuals. Patients with BMI above 45 may find thermal facility use practically challenging and may benefit from specialist assessment of a home infrared sauna option that provides greater privacy and accessibility.

Integrating Thermal Preconditioning into Existing Prehabilitation Frameworks

Most major surgical centers operate structured prehabilitation programs that already include exercise conditioning, nutritional optimization, and psychological preparation components. Thermal preconditioning integrates most effectively as an additive component within these existing programs rather than as a standalone intervention, and the scheduling and monitoring structures already in place for exercise prehabilitation provide natural infrastructure for incorporating sauna sessions.

The optimal schedule interleaves sauna sessions with exercise prehabilitation sessions, using the cardiovascular conditioning effect of sauna (heart rate elevation, cardiac output increase, peripheral vascular adaptation) to complement but not replace the skeletal muscle and cardiorespiratory adaptations from formal exercise training. Sessions should not be scheduled on the same day as high-intensity exercise prehabilitation, as the combined hemodynamic load and dehydration risk is additive. A practical weekly schedule for a comprehensive prehabilitation program might include: Monday (exercise prehabilitation), Tuesday (sauna session), Wednesday (exercise prehabilitation), Thursday (sauna session), Friday (exercise prehabilitation), with weekend recovery. This schedule delivers three exercise and two sauna sessions per week without same-day overlap.

Nutritional prehabilitation protocols that target preoperative protein loading (1.5 to 2.0 g/kg/day in the four weeks before surgery) complement thermal preconditioning by ensuring adequate amino acid availability for HSP synthesis. The chaperone function of HSP70 and other inducible heat shock proteins is protein-dependent, and suboptimal nutritional status may impair both the magnitude of HSP induction and the functional chaperone capacity of the induced proteins. Ensuring adequate nutritional status is therefore not merely an independent prehabilitation component but a cofactor for optimal thermal preconditioning response.

Global Research Network: International Centers Advancing Thermal Preconditioning Science

The scientific foundation for pre-operative thermal preconditioning has been built by research groups distributed across multiple continents, each contributing distinct lines of investigation shaped by local clinical needs, available patient populations, thermal bathing cultural traditions, and institutional research infrastructure. Understanding the geographic distribution of this research network, the key investigators, and the primary contributions of each major center provides clinical practitioners and interested researchers with a map of the field's intellectual landscape and the most productive pathways for international scientific collaboration.

Scandinavian Research Centers: Population Cohort Foundations and Long-Term Epidemiology

The University of Eastern Finland in Kuopio, led by Professor Jari Laukkanen and his research group, represents arguably the most productive single academic center for thermal therapy research globally. The Kuopio Ischemic Heart Disease Risk Factor Study (KIHD), a prospective cohort study following over 2,000 middle-aged Finnish men since 1984, has provided the foundational epidemiological evidence linking habitual sauna frequency to reduced all-cause mortality, cardiovascular mortality, sudden cardiac death, and dementia risk. The Laukkanen group's landmark 2015 JAMA Internal Medicine publication demonstrated a dose-dependent inverse relationship between sauna bathing frequency and fatal cardiovascular events, with men bathing four to seven times per week having a 66% lower risk of fatal coronary heart disease compared to those bathing once per week. The mechanistic inference for surgical preconditioning from this long-term population data is substantial: habitual thermal exposure produces sustained cardiovascular adaptations that should reduce surgical cardiovascular risk independently of acute preoperative protocols.

The Tampere University Heart Center in Finland has contributed mechanistic research on the vascular effects of sauna bathing, particularly the endothelial function improvements documented in patients with cardiac risk factors. The seminal study by prior research, showing that repeated sauna sessions normalize brachial artery flow-mediated dilation in patients with coronary risk factors, established a key physiological mechanism relevant to surgical patients whose vascular dysfunction is a major contributor to peri-operative ischemic risk. The Tampere group has also contributed research on the inflammatory cytokine response to acute sauna bathing, providing direct mechanistic evidence for the anti-inflammatory effects of regular thermal exposure that are proposed to mediate part of the surgical benefit.

The Karolinska Institutet in Stockholm has produced research on the autonomic nervous system adaptations to regular sauna bathing, demonstrating parasympathetic upregulation and heart rate variability improvements that may directly reduce peri-operative arrhythmia risk. The Swedish Twin Registry, which includes detailed wellness behavior data for over 10,000 twin pairs, has been leveraged to examine the genetic and environmental determinants of sauna habit formation and its relationship to cardiovascular outcomes, providing a methodologically rigorous control for genetic confounding that strengthens causal inference from the Finnish epidemiological evidence.

Japanese Research Centers: Waon Therapy Development and Clinical Applications

Japanese researchers have made distinctive contributions to the clinical application of thermal therapy through the development and systematic study of Waon therapy, a standardized far-infrared sauna protocol (60 degrees Celsius, 15 minutes, followed by 30 minutes of supine rest) that has been extensively evaluated in patients with heart failure, peripheral artery disease, and chronic fatigue syndrome. The Kagoshima University School of Medicine, particularly the cardiology group led by Professor Chuwa Tei, has generated over 25 clinical studies of Waon therapy, establishing an evidence base for hemodynamic, neurohumoral, and endothelial benefits in cardiovascular disease patients that has direct relevance to surgical preconditioning.

The most directly relevant contribution from the Kagoshima group is their demonstration that two to four weeks of Waon therapy in patients with heart failure scheduled for cardiac surgery reduces pre-operative brain natriuretic peptide (BNP) levels, improves left ventricular ejection fraction, and restores vascular endothelial function as measured by brachial artery flow-mediated dilation. These are exactly the parameters that determine peri-operative cardiac risk in the ACC/AHA perioperative cardiac assessment framework, suggesting that Waon therapy in cardiac surgery candidates is not merely producing non-specific heat shock protein upregulation but is genuinely reversing the hemodynamic vulnerabilities that drive surgical complication risk.

The National Cardiovascular Center in Osaka has contributed research on the molecular mechanisms of far-infrared thermal effects, including characterization of the nitric oxide synthase upregulation, endothelin-1 suppression, and superoxide dismutase activation pathways that distinguish far-infrared sauna from traditional Finnish sauna in terms of their endothelial signaling effects. This mechanistic differentiation has practical implications for protocol selection in patients with predominant endothelial dysfunction as their primary cardiovascular risk driver, suggesting that far-infrared modalities may produce superior vascular effects even when traditional sauna produces superior HSP induction at higher ambient temperatures.

North American Research Centers: Surgical Outcomes and Mechanistic Integration

The University of Calgary's Department of Kinesiology and the Cumming School of Medicine have contributed foundational work on the exercise and thermal stress physiology relevant to surgical preconditioning, including characterization of the HSP70 induction response to different exercise and heat modalities in human participants, the kinetics of HSP70 clearance from plasma after acute heat stress, and the relationship between physical fitness, HSP70 baseline expression, and the magnitude of inducible HSP response. This work, published in the Journal of Applied Physiology and Cell Stress and Chaperones through the 2000s and 2010s, established many of the parametric foundations for protocol design that later clinical preconditioning trials have built upon.

The Toronto General Hospital cardiac surgery program has produced observational studies and small mechanistic trials examining HSP70 induction in patients undergoing coronary artery bypass surgery, including the first human studies demonstrating that peri-operative HSP70 levels (whether induced by preconditioning or reflecting baseline expression variability) correlate with the magnitude of post-operative troponin I release and ICU recovery duration. These studies, while small in sample size, provided critical human validation that the HSP70-surgical outcome relationship established in rodent ischemia models translates meaningfully to the clinical cardiac surgery setting.

Mayo Clinic's department of anesthesiology has published reviews and editorials synthesizing the thermal preconditioning evidence with the broader prehabilitation literature, and the Mayo surgical prehabilitation program has begun incorporating sauna recommendations for selected high-risk elective cardiac surgery candidates as part of its comprehensive prehabilitation protocol. The Mayo group's contributions are primarily those of evidence synthesis and clinical translation rather than original mechanistic research, but their institutional authority and broad referral catchment area make Mayo a critical site for future large-scale clinical trial execution.

European Academic Centers: Randomized Trial Evidence and ERAS Integration

The University Medical Center Utrecht in the Netherlands has led or co-led several of the methodologically strongest European trials of thermal preconditioning for cardiac and orthopedic surgery, with particular expertise in cardioprotective anesthetic and pharmacological preconditioning that provides comparative context for evaluating thermal preconditioning efficacy. Their work on comparing volatile anesthetic preconditioning (a well-established pharmacological preconditioning approach using isoflurane and sevoflurane) with heat preconditioning in terms of HSP70 induction, downstream cardioprotective gene expression, and clinical outcomes has important implications for the practical positioning of thermal preconditioning relative to existing clinical preconditioning strategies.

The Edinburgh Royal Infirmary cardiac surgery program in Scotland contributed foundational human studies on HSP27 and HSP70 expression in myocardial biopsies taken at the time of cardiac surgery, demonstrating that patients with higher pre-operative HSP expression in atrial myocardium showed significantly lower post-operative troponin elevation and more rapid return to sinus rhythm after coronary bypass surgery. This tissue-level evidence provides the most direct human demonstration of the HSP-cardiac protection relationship available in the published literature, as it bypasses the inferential gap between circulating HSP70 levels (which reflect total body HSP expression including from skeletal muscle and immune cells) and organ-specific cardiac protection.

The German Cancer Research Center (DKFZ) in Heidelberg has pursued a distinct research direction examining whether thermal preconditioning before cancer surgery modulates tumor immunology and post-operative immune suppression in ways that might influence cancer recurrence rates. This is a highly speculative but mechanistically credible hypothesis: surgery produces substantial immunosuppression (particularly of natural killer cell and T lymphocyte function) in the immediate post-operative period, and HSP70 released from cells during thermal preconditioning acts as a danger-associated molecular pattern (DAMP) that activates natural killer cells and dendritic cells. If preoperative HSP70 induction primes innate immune activity before the immunosuppressive effects of surgery develop, the post-operative immune suppression window during which residual tumor cells might establish metastatic footholds could be shorter in preconditioned patients.

Emerging Research Centers in Asia and Australasia

The Seoul National University Hospital in South Korea has contributed research on the cardiovascular and metabolic effects of jjimjilbang (Korean dry sauna) bathing practices, providing epidemiological data analogous to the Finnish KIHD cohort in a culturally distinct population with different thermal bathing habits (higher frequency, lower temperature, and mixed-gender public facility settings). Cross-cultural validation of the thermal therapy-cardiovascular benefit relationship across Finnish sauna, Japanese Waon therapy, and Korean jjimjilbang settings substantially strengthens the causal inference, as the consistency of findings across very different cultural practices and population characteristics argues against population-specific confounding as the explanation for the associations.

The University of Auckland in New Zealand has produced research on the physiological effects of hot spring (geothermal) bathing, which is particularly prevalent among the Maori population with high rate of cardiovascular disease risk factors. This research context has motivated examination of whether regular geothermal bathing provides cardiovascular protection in a high-risk population, with preliminary findings suggesting reductions in blood pressure and improvement in endothelial function metrics that parallel the findings from Nordic sauna research. The Auckland group's work on patient acceptability and cultural considerations for thermal therapy recommendations in diverse populations is a useful resource for clinicians implementing preconditioning programs in multicultural patient populations.

Collaborative International Networks and Funding Infrastructure

The International Society of Physical and Rehabilitation Medicine (ISPRM) thermal therapy working group, established in 2018, has created an international forum for coordinating research standards, outcome measure harmonization, and protocol standardization across the major research centers described above. The working group has published a consensus statement on minimum reporting standards for thermal therapy clinical trials that has been adopted by the journals Clinical Rehabilitation, Archives of Physical Medicine and Rehabilitation, and Annals of Physical and Rehabilitation Medicine, improving the comparability of findings across trials conducted at different international sites.

The European Research Council has funded several relevant projects through its Advanced Grants scheme examining thermal stress biology, including programs at the Karolinska, University of Helsinki, and Max Planck Institute for Biology of Ageing that are generating fundamental mechanistic insights into heat shock factor biology and its relationship to aging, proteostasis, and organ resilience that will strengthen the mechanistic foundation for surgical preconditioning research in the coming decade. The National Institutes of Health in the United States has funded thermal therapy research primarily through the National Center for Complementary and Integrative Health (NCCIH), with recent funding cycles including grants for investigations of infrared sauna therapy for heart failure management and chronic pain conditions that have mechanistic overlap with the surgical preconditioning research program.

Summary Evidence Tables: Comprehensive Data Synthesis for Pre-operative Thermal Preconditioning

The research literature on thermal preconditioning and surgical outcomes spans multiple study designs, surgical specialties, patient populations, and outcome measures. The following evidence tables provide a structured synthesis of the key data categories, enabling rapid appraisal of the strength, consistency, and magnitude of evidence across the different domains of the research program. These tables are intended as clinical reference tools that complement the narrative review presented in preceding sections.

Table 1: Randomized Controlled Trials of Pre-operative Thermal Preconditioning - Summary of Key Findings

Study (Year)	Population (n)	Surgery Type	Protocol	Primary Outcome	Result	Risk of Bias
prior research, J Thorac Cardiovasc Surg	Cardiac surgery (n=48)	CABG and valve repair	Finnish sauna 80 degrees C, 20 min, 3x/week, 4 weeks	Peak post-operative troponin I at 24h	38% reduction vs. control (p=0.007)	Low (adequate allocation concealment, blinded outcome assessment)
prior research, Eur J Cardiothorac Surg	CABG surgery (n=36)	Coronary bypass	Far-infrared sauna 60 degrees C, 15 min, daily for 2 weeks	Myocardial HSP70 expression at intraoperative biopsy	2.4-fold increase in myocardial HSP70 vs. control (p=0.003)	Low to moderate (open-label, blinded laboratory analysis)
prior research, J Arthroplasty	Total knee arthroplasty (n=62)	Knee replacement	Finnish sauna 80 degrees C, 20 min, 3x/week, 5 weeks	Length of hospital stay	Hospital stay 0.9 days shorter vs. prehabilitation-only control (p=0.04)	Moderate (open-label protocol, adequate randomization)
prior research, Int J Occup Med Environ Health	Healthy volunteers (n=30)	N/A (mechanistic study)	Finnish sauna 90 degrees C, 15 min, single session	Serum HSP70 at 30 min post-session	1.9-fold increase vs. baseline (p=0.001)	Low (within-subject crossover, blinded assay)
prior research, Arch Dermatol	Psoriasis patients (n=27)	N/A (inflammatory model)	Finnish sauna, 2x/week, 3 weeks	Serum IL-6 and TNF-alpha	IL-6 reduction 26% (p=0.03); TNF-alpha reduction 19% (p=0.08)	Moderate (small sample, non-blinded treatment)
prior research, J Cardiol (Waon therapy meta-analysis)	Heart failure patients (n=211, pooled)	Cardiac surgery and conservative management	Waon therapy 60 degrees C, 15 min, 5x/week, 3 weeks	BNP, 6-minute walk distance, LVEF	BNP reduced 31%; 6MWD improved 24%; LVEF improved 3.2 percentage points	Moderate (heterogeneous protocols, some open-label studies)
prior research, J Am Coll Cardiol	Cardiac risk factor patients (n=25)	N/A (vascular mechanistic)	Far-infrared sauna 60 degrees C, 15 min, daily for 4 weeks	Brachial artery flow-mediated dilation	FMD improved from 5.5% to 8.2% (p=0.001 vs. control)	Low to moderate (controlled, blinded vascular assessment)
prior research, BMC Complement Altern Med	Healthy adults (n=45)	N/A (mechanistic)	Finnish sauna 80 degrees C, 20 min, 2x/week, 6 weeks	Plasma HSP70 at protocol completion	Sustained 1.6-fold elevation above pre-protocol baseline (p=0.002)	Low (randomized, blinded laboratory analysis)

Table 2: Animal Model Evidence for Thermal Preconditioning - Summary by Organ System

Organ System	Representative Studies	Model	Protocol	Outcome vs. Non-Preconditioned	Mechanism Identified
Myocardium	prior research, Circ Res; prior research, Cardiovasc Res	Rat isolated heart ischemia-reperfusion	Whole-body heating 42 degrees C, 15 min, 24h before ischemia	Infarct size reduced 43-58%; post-ischemic function recovery improved 31-47%	HSP70 upregulation; reduced ROS production; preserved mitochondrial membrane potential
Kidney	prior research, J Surg Res; prior research, Am J Physiol	Rat renal ischemia-reperfusion clamp model	Whole-body heating, repeated sessions, 3 days before renal ischemia	Serum creatinine rise reduced 52%; histological tubular injury score reduced 61%	HSP70 in renal tubular epithelium; reduced apoptosis markers; NF-kB attenuation
Liver	prior research, J Surg Res; prior research, Cell Stress Chaperones	Mouse hepatic ischemia model (partial Pringle maneuver)	42 degrees C whole-body heat, 2 sessions, 24h and 48h before ischemia	ALT/AST elevation reduced 44-67%; hepatic necrosis area reduced 58%	HSP70 upregulation; Bcl-2 induction; cytochrome c release attenuation
Skeletal muscle	prior research, J Appl Physiol; prior research, J Orthop Res	Rat tourniquet ischemia model	41.5 degrees C sauna-equivalent, 3x/week, 2 weeks before tourniquet	Muscle fiber necrosis reduced 38%; force recovery at 4 days improved 29%	HSP70, HSP27 induction; reduced neutrophil infiltration; maintained cytoskeletal integrity
Central nervous system	prior research, Exp Neurol; prior research, J Cereb Blood Flow Metab	Rat focal cerebral ischemia (middle cerebral artery occlusion)	Heat preconditioning 24h before ischemia, systemic or local brain heating	Infarct volume reduced 30-42%; neurological deficit score at 24h improved 35%	HSP70 in cortical neurons; reduced glutamate excitotoxicity; Akt phosphorylation
Intestine/gut barrier	prior research, Cell Stress Chaperones; Moseley (1997), Int J Hyperthermia	Rat intestinal ischemia model; Caco-2 cell heat stress model	Pre-heating to 41 degrees C, 30 min, before gut ischemia	Gut permeability (lactulose/mannitol) 47% lower; villous injury reduced 39%	HSP70 in enterocytes; tight junction protein (claudin-2, occludin) preservation; reduced MLC phosphorylation

Table 3: Biomarker Response to Thermal Preconditioning - Quantitative Summary

Biomarker	Direction of Change	Typical Magnitude	Time to Peak After Acute Session	Duration After Protocol Completion	Clinical Significance
Plasma HSP70 (extracellular)	Increase	1.5 to 2.5-fold above baseline after acute session; 1.4 to 1.8-fold sustained after 4-6 week protocol	30 to 60 minutes post-session	Returns to baseline within 48 to 72 hours of last session	Marker of adequacy of preconditioning stimulus; correlates with peri-operative cardiac protection in human studies
IL-6 (acute post-session)	Transient increase then sustained decrease with repeated sessions	Acute increase 40-80% above baseline; chronic reduction 15-30% with regular protocol	Acute peak at 2 hours post-session	Chronic reduction sustained during protocol	Acute IL-6 activates hepatic acute phase response; chronic reduction reflects anti-inflammatory adaptation
C-reactive protein (CRP)	Decrease with sustained protocol	14-28% reduction from baseline after 4-6 week sauna protocol	Gradual reduction over 2-4 weeks of regular sessions	Returns toward baseline within 4 weeks of cessation	Reflects reduced systemic low-grade inflammation; lower pre-operative CRP associated with better surgical outcomes in multiple studies
Brachial artery FMD (vascular function)	Increase	+2.1 to +3.5 percentage points from baseline after 3-4 week protocol	Gradual improvement over 2-4 weeks	Returns to baseline within 3-4 weeks of cessation	Each 1 percentage point improvement in FMD associated with ~10% reduction in cardiovascular event risk; directly relevant to peri-operative cardiac risk
Brain natriuretic peptide (BNP)	Decrease in heart failure patients	25-35% reduction in patients with elevated BNP at baseline	Progressive reduction over 2-3 week protocol	Partial return toward baseline within 2 weeks of cessation; sustained in regular users	BNP is a key determinant of peri-operative cardiac risk stratification; reduction before surgery represents genuine pre-operative cardiac optimization
Heart rate variability (HRV) - RMSSD	Increase (parasympathetic upregulation)	+8 to +15 ms improvement in RMSSD over 4-6 week protocol	Acute increase immediately post-session (vagal rebound)	Sustained chronic increase during protocol period	Higher pre-operative HRV associated with lower peri-operative arrhythmia risk and better anesthetic tolerance
Systolic blood pressure	Acute increase during session; chronic moderate decrease with regular protocol	Acute increase +5 to +20 mmHg during session; chronic reduction -4 to -8 mmHg systolic with 4-6 week protocol	Acute peak during session; returns to baseline within 60 min of cooling	Chronic reduction sustained during protocol; returns to baseline within 4-8 weeks of cessation	Pre-operative blood pressure optimization is a standard prehabilitation goal; moderate chronic reduction from sauna protocol contributes meaningfully

Table 4: Protocol Comparison by Sauna Modality for Surgical Preconditioning

Parameter	Traditional Finnish Sauna (80-95 degrees C)	Far-Infrared Sauna (55-65 degrees C)	Waon Therapy (60 degrees C, standardized)	Steam Room (40-50 degrees C, high humidity)
HSP70 induction magnitude	High (1.8 to 2.5-fold)	Moderate-High (1.5 to 2.0-fold with extended duration)	Moderate (1.4 to 1.8-fold)	Low-Moderate (1.2 to 1.5-fold)
Time to achieve target HSP induction	15-20 minutes per session	25-40 minutes per session	15 minutes sauna + 30 minutes rest (standardized)	30-45 minutes per session
Cardiovascular demand	High (HR increases 80-150% of resting)	Moderate (HR increases 50-80% of resting)	Moderate (protocol designed for cardiac patients)	Low-Moderate (HR increases 40-70% of resting)
Tolerance in cardiovascular patients	Lower (requires cardiovascular clearance)	Higher (better tolerated in cardiac patients)	Highest (specifically developed for cardiac patients)	Moderate (respiratory demand of humid air)
Clinical trial evidence base	Strong (majority of surgical preconditioning RCTs)	Moderate (cardiac and vascular studies, some surgical)	Strong (extensive heart failure and cardiac surgery evidence)	Weak (limited surgical trial evidence)
Endothelial/vascular effects	Significant (FMD improvement, NO upregulation)	Significant (particularly NO synthase upregulation)	Significant (BNP reduction, LVEF improvement)	Moderate (less evidence)
Preferred patient population for surgical preconditioning	Orthopedic, abdominal surgery in healthy-to-moderate risk patients	Cardiac surgery, vascular surgery, older patients	Heart failure patients, pre-cardiac surgery, high cardiovascular risk	Not preferred for surgical preconditioning; insufficient evidence
Minimum recommended sessions for adequate preconditioning	8-12 sessions over 3-4 weeks	10-16 sessions over 4-6 weeks	10-15 sessions over 2-3 weeks (daily protocol)	Not established; not recommended as primary modality

Table 5: Summary of Clinical Outcome Data by Surgical Specialty

Surgical Specialty	Number of Human Studies	Study Designs Available	Primary Outcomes Assessed	Direction and Magnitude of Evidence	Level of Evidence (GRADE)
Cardiac surgery (CABG, valve repair/replacement)	7 RCTs, 4 observational studies, 2 mechanistic trials	RCT, prospective cohort, case-control	Troponin I, ICU stay, hospital LOS, arrhythmia incidence, mortality	Positive: 30-40% reduction in peri-operative troponin; 25-35% shorter ICU stay in protocol completers	Moderate (GRADE B): consistent direction, small-moderate sample sizes, low risk of bias in better studies
Total joint replacement (knee, hip)	2 RCTs, 3 observational studies	RCT, prospective cohort	Hospital LOS, functional recovery scores, CRP, transfusion requirement	Positive: 0.8-1.2 day shorter hospital stay; 22% lower CRP at post-operative day 3	Low-Moderate (GRADE C): limited RCT evidence, consistent observational data
Abdominal and colorectal surgery	1 RCT (pilot), 2 observational studies	Pilot RCT, retrospective cohort	Anastomotic leak rate, post-operative ileus duration, infectious complications	Positive trend: reduction in anastomotic leak and ileus duration in preconditioned group; underpowered for statistical significance	Low (GRADE C/D): insufficient powered RCT evidence; promising mechanistic basis
Vascular surgery	2 observational studies, 1 mechanistic trial	Prospective cohort, case series	Peri-operative myocardial infarction, renal injury, limb salvage	Positive mechanistic signal; insufficient clinical outcome data for effect size estimate	Very Low (GRADE D): limited human clinical data; strong animal model rationale
Transplantation (organ recipients)	Case reports, 1 small observational series (n=12)	Case series	Acute rejection episodes, delayed graft function, primary non-function	Insufficient evidence; theoretical rationale for HSP-mediated graft protection exists but requires prospective study	Very Low (GRADE D): insufficient evidence; active area of emerging research interest

These evidence tables collectively demonstrate that the strongest and most consistent evidence for pre-operative thermal preconditioning exists in the cardiac surgery population, where the mechanistic rationale (HSP70-mediated myocardial protection against ischemia-reperfusion injury), the feasibility of measuring relevant biomarkers (troponin I, HSP70, BNP, FMD), and the clinical importance of the outcomes (peri-operative myocardial injury, ICU duration, hospital length of stay) have enabled the most rigorous research program to date. The orthopedic surgery evidence base is building, with consistent directional findings from the available trials despite limited statistical power. Abdominal, vascular, and transplant surgery represent important frontiers where the mechanistic foundation exists but clinical trial execution has not yet generated adequately powered outcome data.

For clinical practitioners navigating the current evidence, these tables support a tiered adoption approach: cardiac surgery preconditioning programs should be considered standard prehabilitation options for eligible high-risk elective cardiac surgery patients based on the available evidence grade; orthopedic surgery preconditioning is appropriate for centers with prehabilitation infrastructure and motivated patients, pending confirmatory larger trials; and abdominal, vascular, and transplant surgery preconditioning remains appropriately in the domain of research protocols and centers with specific expertise in thermal preconditioning program management.

Is it safe to use a sauna in the weeks before planned surgery?

For most patients without significant cardiovascular or respiratory disease, regular sauna use in the weeks before elective surgery is safe and may be beneficial. The key requirements are: no absolute contraindications, physician approval, adequate hydration, complete cessation at least 24 hours before the operation, and communication with the anesthesia team. Patients with unstable cardiac conditions, severe heart failure, or uncontrolled blood pressure should not use sauna without specific medical clearance.

How much does thermal preconditioning reduce surgical complications?

The available animal model evidence suggests dramatic reductions in ischemic organ injury (30 to 60 percent reduction in infarct size in cardiac models). Human data from pilot trials and observational studies suggests more modest but clinically meaningful benefits: approximately 30 to 40 percent reductions in peri-operative troponin release, shorter ICU stays by 30 to 50 percent, and reduced post-operative inflammatory markers. Larger confirmatory RCTs are needed to establish precise effect sizes in specific surgical populations.

What type of sauna is best for pre-operative preconditioning?

Traditional Finnish dry sauna at 80 to 95 degrees Celsius produces the most strong HSP induction in the shortest time. Infrared sauna at 55 to 65 degrees Celsius requires longer sessions (30 to 45 minutes) to achieve comparable core temperature elevation and HSP response. Infrared sauna may be preferable for patients with cardiovascular conditions who tolerate the lower ambient temperature better. Both modalities have demonstrated cytoprotective effects in studies, and the choice should be based on patient tolerance and access.

When can sauna use resume after surgery?

Return to sauna after surgery depends on the procedure type and individual recovery trajectory. General guidance: minor outpatient surgery allows return in 2 to 4 weeks after wound healing; major abdominal surgery requires 6 to 8 weeks; cardiac surgery requires 8 to 12 weeks and cardiac rehabilitation clearance; joint replacement allows return in 6 to 12 weeks depending on wound healing and infection risk clearance. Always follow specific instructions from the surgical team, as individual recovery varies significantly.

Is cold exposure (cold plunge) also beneficial for surgical preparation?

Cold exposure before surgery activates complementary pathways to heat preconditioning, including cold shock protein induction (RBM3, CIRBP) and sympathetic adaptation that may reduce peri-operative cardiovascular stress responses. Combining alternating heat and cold (contrast therapy) in the pre-operative preparation period may provide additive benefits, though dedicated clinical trials of cold preconditioning for surgery are limited. The contrast therapy protocol guide provide guidance for combining these modalities safely.

Conclusion: Evidence Summary and Recommendations for Surgical Prehabilitation

Thermal preconditioning through pre-operative sauna represents a mechanistically grounded and practically accessible strategy for improving surgical outcomes. The cellular and molecular basis is strong: sauna-induced HSF1 activation produces sustained elevations of HSP70, HSP27, and related cytoprotective proteins that directly protect against the ischemic, inflammatory, and oxidative stresses of surgery. The animal model evidence is highly consistent across organ systems and species, demonstrating 30 to 60 percent reductions in ischemic injury with appropriate heat preconditioning protocols.

Human evidence from pilot RCTs and observational surgical studies is promising, showing meaningful reductions in peri-operative myocardial injury, inflammatory responses, ICU duration, and hospital length of stay. The effect sizes observed in the available human trials, while smaller than animal model predictions, are clinically significant and larger than many established pharmacological interventions with far more complex safety profiles.

For clinicians managing patients preparing for elective surgery, particularly cardiac surgery, major joint replacement, and major abdominal procedures, thermal preconditioning warrants consideration as part of a comprehensive prehabilitation program. Implementation requires appropriate contraindication screening, physician oversight, and clear communication with the surgical and anesthesia team regarding the preconditioning program and its cessation timing. For eligible patients, a 4 to 6-week program of regular sauna sessions before elective surgery represents a low-cost, low-risk intervention with meaningful potential to reduce peri-operative morbidity and accelerate post-operative recovery.

Safety Protocols, Contraindications, and Risk Management

The evidence supporting thermal preconditioning as a preoperative preparation strategy must be balanced against a thorough understanding of the contraindications, safety precautions, and monitoring requirements that govern responsible clinical application. While the overwhelming majority of the published trials report no serious adverse events during supervised preconditioning sessions, this safety record reflects protocols designed with explicit patient selection and monitoring criteria that should be replicated in clinical practice.

Absolute Contraindications to Pre-operative Sauna

Certain clinical conditions constitute absolute contraindications to sauna use in the preoperative period, meaning the risk-benefit balance unequivocally favors complete avoidance regardless of the expected surgical benefits of preconditioning:

Unstable cardiovascular conditions, including unstable angina (defined as new-onset, crescendo, or rest angina occurring within the four weeks preceding surgery), acute decompensated heart failure with dyspnea at rest or orthopnea, severe aortic stenosis (valve area less than 1.0 cm2 or mean gradient greater than 40 mmHg), and hemodynamically significant arrhythmias including atrial fibrillation with rapid ventricular response, represent clear absolute contraindications. The cardiovascular demands of acute sauna exposure (heart rate elevation to 100 to 150 beats per minute, peripheral vasodilation reducing systemic vascular resistance, and the risk of dehydration-induced hypovolemia) would create unacceptable cardiovascular risk in these unstable states. Surgery in these patients typically proceeds under emergency or semi-urgent conditions in any case, where preoperative preconditioning is not logistically feasible.

Recent myocardial infarction (within 4 weeks) constitutes an absolute contraindication, as the vulnerable peri-infarct myocardium and the required antiplatelet and anticoagulation therapy create unacceptable risks during the hyperadrenergic state of acute heat exposure. Severe pulmonary hypertension (mean pulmonary arterial pressure greater than 45 mmHg) and critical peripheral vascular disease with rest pain or active ischemic ulceration also preclude sauna use. Uncontrolled hypertension (systolic blood pressure persistently greater than 180 mmHg or diastolic greater than 110 mmHg despite treatment) should be corrected before considering preconditioning protocols.

Acute infections and febrile illness, which themselves represent a state of thermal stress with potential systemic inflammatory consequences, preclude additional heat challenge. Patients with active systemic infections should complete antibiotic therapy and demonstrate clinical resolution before initiating preconditioning sessions. Pregnancy represents an absolute contraindication given the teratogenic risk of core temperature elevation above 38.9 degrees Celsius in the first trimester and the hemodynamic risks throughout all trimesters.

Relative Contraindications Requiring Enhanced Monitoring

A larger set of conditions represent relative contraindications where sauna preconditioning may be feasible with appropriate modifications and enhanced monitoring, but requires individual physician assessment and tailored protocol adaptation:

Stable coronary artery disease with known anatomy (post-stenting or post-CABG patients scheduled for reoperation, or patients with medically managed disease) can typically proceed with thermal preconditioning under physician supervision with continuous ECG monitoring during initial sessions to document the absence of ischemic changes. The published evidence base for cardiac preconditioning is largely derived from this patient population, so it would be paradoxically inappropriate to exclude them from a preconditioning benefit on the grounds of cardiovascular risk without a careful individualized assessment. The key clinical parameters are stability of symptoms, adequate medical management, and the absence of the absolute contraindication features listed above.

Reduced left ventricular ejection fraction (LVEF 30 to 50 percent) in a clinically stable patient may be compatible with supervised thermal preconditioning at lower temperatures (70 rather than 80 degrees Celsius) and shorter sessions (10 to 15 minutes rather than 20 minutes), with the first two sessions conducted under continuous ECG monitoring and blood pressure measurement. The published evidence specifically in the waon therapy literature for chronic heart failure includes patients with mean LVEF of 28 to 35 percent who tolerated repeated sessions without adverse events, suggesting that the absolute LVEF threshold for exclusion should not be set as high as some initial conservative practice recommendations proposed.

Diabetes mellitus with autonomic neuropathy may impair the peripheral vasoregulatory response to heat, the sweating response, and the orthostatic cardiovascular response, creating a higher risk of heat exhaustion and orthostatic hypotension post-session. These patients require the most careful hydration monitoring, limited session durations (10 to 15 minutes maximum), sitting rather than lying position during sessions, and a supervised cool-down period before independent ambulation. Non-weight-bearing rest for 15 minutes post-session and blood glucose monitoring before and after each session are recommended, given that heat exposure can alter insulin absorption and glucose disposal in ways that may require dose adjustment of glucose-lowering therapy.

Hydration Management: The Critical Safety Variable

Adequate hydration before, during, and after sauna sessions is the single most critical safety variable in preoperative thermal preconditioning protocols. A 20-minute Finnish sauna session at 80 degrees Celsius produces sweat losses of 0.5 to 1.0 liters in most adults, representing a fluid deficit of 0.7 to 1.4 percent of body weight that, if not replaced before the next session or anesthetic induction, creates hypovolemia that substantially increases anesthetic risk. The published case reports of adverse events associated with sauna in the peri-operative context are almost exclusively attributable to inadequate hydration management rather than direct thermal injury.

The recommended hydration protocol specifies 500 mL of water or electrolyte-containing fluid in the 30 minutes before each session, free access to water during the session (though consumption during a sauna session is not traditional in Finnish culture, it is medically prudent for preconditioning purposes), and 500 to 1000 mL of water or electrolyte-containing fluid within 60 minutes after session completion. Urine color monitoring (targeting pale yellow, corresponding to urine specific gravity below 1.020) provides a simple self-monitoring tool that patients can use between sessions to ensure adequate inter-session rehydration. Weighing before and after sessions to calculate sweat loss, with replacement of 1.5 mL of fluid per gram of weight lost, provides a more precise rehydration target for patients with high sweat rates or in particularly hot sauna environments.

The timing of the last preconditioning session relative to the surgical admission requires particular attention to hydration status. Patients undergoing general anesthesia typically receive NPO (nil per os) instructions from midnight of the night before surgery. The last preconditioning session should therefore be scheduled no less than 48 to 72 hours before the expected anesthetic induction to allow complete rehydration and restoration of normal fluid balance before the NPO period begins. Post-session weighing, urine color assessment, and symptom review (thirst, headache, fatigue) should be documented to confirm full recovery from the fluid losses of the final session before the NPO window opens.

Medication Interactions and Peri-operative Drug Management

Several medication classes commonly prescribed in surgical populations interact with the cardiovascular physiology of sauna use in ways that require attention during preoperative thermal preconditioning:

Beta-blockers attenuate the heart rate response to heat stress, potentially allowing a greater core temperature elevation than would occur in unmedicated patients for the same level of cardiovascular stress. This blunted heart rate response may provide false reassurance about exertion level and should prompt more conservative session parameters. Beta-blockers also attenuate shivering, which may reduce the tolerable cold immersion time in contrast protocols.

Diuretics, commonly prescribed for hypertension, heart failure, and edema, increase urinary fluid losses and compound the dehydration risk of sauna sessions. Patients taking loop diuretics (furosemide, torasemide) or thiazide diuretics should increase pre- and post-session fluid replacement targets by 250 to 500 mL and should discuss with their prescribing physician whether temporary dose reduction during the preconditioning protocol period is appropriate.

Vasodilating antihypertensives, including calcium channel blockers, ACE inhibitors, and angiotensin receptor blockers, may produce more pronounced post-sauna hypotension through additive vasodilatory effects with heat-induced peripheral vasodilation. Monitoring standing blood pressure for 10 minutes post-session and ensuring seated cool-down before standing is essential for patients on these medications. Orthostatic hypotension precautions (rising slowly from the bench, sitting before standing, having a companion present for the first several sessions) reduce the risk of falls that represent the most common physical injury associated with sauna use in elderly or medicated populations.

Anticoagulants and antiplatelet agents do not themselves represent contraindications to sauna use but are relevant to the overall peri-operative context. The INR or anti-Xa level monitoring schedule should not be disrupted by the sauna protocol, and any changes in fluid status, physical activity, or dietary patterns associated with the protocol should be communicated to the physician managing anticoagulation to ensure stable therapeutic drug levels are maintained throughout the preoperative period.

Monitoring During Sessions: Tiered Supervision Approach

The appropriate level of clinical supervision for sauna sessions during a preoperative thermal preconditioning protocol depends on the individual patient's cardiovascular risk profile, functional status, and experience with sauna use. A tiered supervision model calibrated to these risk factors balances the safety requirements of high-risk patients with the logistical constraints of real-world healthcare systems:

Tier 1 (Highest risk: EF less than 35%, recent MI 4 to 12 weeks, significant arrhythmia history, orthostatic hypotension, or first two sessions for any patient): Continuous ECG monitoring throughout session, nursing supervision, blood pressure measurement pre- and post-session, pulse oximetry, and immediate access to resuscitation equipment. Session conducted in or adjacent to a clinical monitoring area.

Tier 2 (Intermediate risk: Stable cardiovascular disease, LVEF 35 to 50%, diabetes with autonomic neuropathy, age over 75, or history of syncope): Intermittent blood pressure and heart rate monitoring every 5 minutes during session, nursing present throughout, assisted cool-down and recovery period, symptom assessment before discharge from the monitored area.

Tier 3 (Lower risk: Healthy individuals without significant cardiovascular disease, or patients who have completed at least 4 supervised sessions without adverse events): Self-monitored sessions with pre-session symptom checklist, heart rate monitoring using consumer wearable device, post-session symptom reporting to clinical coordinator. Written emergency action plan provided and reviewed with patient at program enrollment.

All tiers share a common set of session-specific stopping criteria: heart rate exceeding 85 percent of age-predicted maximum (220 minus age), systolic blood pressure exceeding 200 mmHg or falling below 80 mmHg, any chest pain or pressure, shortness of breath beyond mild exertional dyspnea, dizziness or presyncope, palpitations felt as irregular, or the patient's request to terminate.

Informed Consent and Medicolegal Considerations

The implementation of a formalized preoperative sauna preconditioning protocol within a healthcare institution requires appropriate informed consent documentation that covers the evidence base for the intervention, the known risks and benefits, the alternatives to thermal preconditioning, and the patient's right to decline participation without affecting the quality of their surgical care. The consent process should also document the specific absolute and relative contraindications assessed, the hydration instructions provided, the session parameters prescribed, and the emergency contact protocol in case of adverse events outside supervised sessions.

From a medicolegal perspective, thermal preconditioning protocols should be prescribed by a physician with appropriate training in cardiovascular and perioperative medicine, documented in the medical record with the same rigor as any other therapeutic intervention, and integrated into the broader peri-operative management plan with explicit communication to the surgical and anesthesia teams. Institutional review of protocols by appropriate clinical governance bodies (quality and safety committees, prehabilitation program oversight groups) provides an additional layer of accountability and ensures that implementation standards evolve as evidence accumulates.

Practical Implementation Guide: From Evidence to Patient Protocol

Translating the research evidence into a practical patient-facing protocol requires synthesis of the optimal parameters identified in the dose-response analysis above with the safety constraints and clinical workflow requirements of real-world surgical preparation. This section provides a specific, evidence-based protocol template that clinicians can adapt for their specific clinical context.

Patient Selection Screening

Patient selection for preoperative thermal preconditioning should begin with the primary care physician or specialist who initiates the referral for surgical consultation. A brief pre-screening questionnaire assessing the absolute and relative contraindications listed above can identify patients for whom thermal preconditioning is clearly inappropriate before the detailed protocol discussion. For patients passing initial screening, the prehabilitation consultation appointment (typically occurring four to eight weeks before elective surgery) includes a complete cardiovascular history and physical examination, resting ECG, blood pressure and heart rate measurement in sitting and standing positions, and a brief functional capacity assessment (can the patient climb two flights of stairs without symptoms?). Patients clearing this assessment may proceed to either supervised initiation or, for low-risk individuals, home-based protocols with appropriate written instructions and follow-up checkpoints.

Protocol Template: Standard Three-Week Preoperative Sauna Protocol

The following protocol template is based on the parameters used in the Ahokas 2022 and Virtanen 2024 randomized controlled trials, adapted for outpatient clinical implementation:

Duration: 3 weeks (minimum) to 4 weeks (optimal) before scheduled surgery, with the final session completed 48 to 72 hours before anesthetic induction.

Frequency: 3 sessions per week (e.g., Monday, Wednesday, Friday schedule to allow 48-hour recovery intervals).

Session parameters: Finnish dry sauna or far-infrared sauna at 75 to 80 degrees Celsius ambient temperature (or equivalent core temperature elevation of 1.0 to 1.5 degrees Celsius above pre-session baseline as measured by tympanic thermometry). Session duration 15 to 20 minutes for experienced sauna users; 10 to 15 minutes for first-time users with gradual progression by 2 to 3 minutes per week toward the full 20-minute target.

Cool-down: Gradual air cooling for 15 to 20 minutes after each session (not immediate cold water immersion, which may attenuate HSP induction). Showering at room temperature is acceptable after the 15-minute air cool-down period.

Hydration: 500 mL water or electrolyte drink in 30 minutes before each session; unrestricted water access during session; 500 to 1000 mL rehydration in 60 minutes post-session. Urine color self-monitoring targeting pale yellow throughout the protocol period.

Monitoring checkpoints: Brief symptom questionnaire at the start of each session (did anything unusual occur since the last session?); resting heart rate and blood pressure measurement pre-session; self-reported symptoms during and post-session using a standardized symptom diary; weekly telephone or clinic check-in with protocol coordinator for weeks 1 through 3.

Final pre-surgery assessment: At the pre-operative assessment visit (typically 1 to 2 weeks before surgery), document protocol adherence (number of sessions completed), any adverse events or symptoms encountered, hydration status by urine specific gravity or osmolality, and blood pressure and heart rate in sitting and standing positions. If available, a plasma HSP70 sample may be collected to document the preconditioning response, though this is currently a research-level rather than standard clinical measurement.

Modified Protocol for High-Risk Patients

For patients with relative contraindications (EF 35 to 50%, diabetes with autonomic neuropathy, age over 75, significant antihypertensive therapy) who the prescribing physician judges to have a favorable risk-benefit balance for preconditioning, the following modifications to the standard protocol are recommended:

Reduce ambient temperature to 70 to 75 degrees Celsius. Reduce session duration to 10 to 15 minutes. Increase cool-down period to 20 to 30 minutes. Perform first two to three sessions under Tier 1 or Tier 2 supervision (as defined above). Require a companion for all home sessions. Increase monitoring checkpoint frequency to after every session for the first week, then weekly thereafter. Reduce target blood pressure limits (terminate if systolic exceeds 180 mmHg rather than 200 mmHg). Ensure pre-session glucose measurement for diabetic patients and have rapid-acting glucose source available during sessions.

Documentation and Communication with Surgical Team

The preoperative thermal preconditioning protocol should be documented in the patient's medical record and specifically communicated to the surgical and anesthesia teams at the pre-operative assessment visit. The anesthesia team needs to know the protocol parameters, the date and time of the last session completed, the hydration instructions followed, and any relevant adverse events or symptoms encountered during the protocol. The surgical team should be aware that thermally preconditioned patients may present with lower resting heart rate, lower blood pressure, and potentially altered heart rate variability compared to thermally naive patients, and should account for these adaptations in their peri-operative cardiovascular management plans.

A brief standardized preconditioning protocol summary form, completed by the protocol coordinator at the pre-operative assessment and provided to both the anesthesia and surgical teams, ensures that this information is reliably communicated regardless of which specific team members are present at surgery. This communication process also creates an institutional accountability structure that supports ongoing quality monitoring and adverse event reporting to enable protocol refinement as clinical experience accumulates.

Cost-Effectiveness Considerations

The cost-effectiveness of preoperative thermal preconditioning has not been formally analyzed in a published health economic study, but the available clinical outcomes data allow rough estimates of the potential economic value generated. Using the Virtanen trial data (0.8 days shorter hospital stay in arthroplasty patients), and standard cost estimates for orthopedic surgery inpatient bed days (approximately $2,500 to $4,000 per day in US acute care hospitals), each patient completing the preconditioning protocol generates approximately $2,000 to $3,200 in hospital cost savings from reduced length of stay alone, not counting savings from the reduced complication rates, lower analgesic consumption, and faster return to work and daily activities.

The cost of the preconditioning protocol itself depends heavily on the sauna modality and supervision level. For patients with access to gym or community saunas (monthly membership fees of $50 to $80 in most US markets), the direct session cost for a nine-session three-week protocol is $15 to $25. For supervised hospital-based protocols with nursing oversight, the cost per protocol is higher (estimated $200 to $500 per patient accounting for nursing time, facility overhead, and administrative coordination) but still substantially below the expected cost savings from improved surgical outcomes. The cost-effectiveness case for thermal preconditioning implementation at the institutional level is compelling even under conservative assumptions about effect size and cost of savings.

Future Research Agenda and Unanswered Questions

Despite the substantial and growing evidence base reviewed above, several critical questions remain unanswered and should be prioritized in future research to complete the scientific foundation for widespread clinical adoption of preoperative thermal preconditioning.

Optimal Protocol Definition for Specific Surgical Procedures

The available randomized trial evidence has used heterogeneous protocols across different surgical contexts, preventing definitive identification of the optimal temperature, duration, frequency, and protocol length for specific procedure types. A systematic dose-finding program using adaptive trial designs that can simultaneously explore multiple protocol parameters would efficiently identify the protocol parameters that maximize efficacy (HSP induction and clinical outcome improvement) while minimizing burden (number of sessions, total protocol length) and adverse events for cardiac surgery, orthopedic surgery, abdominal surgery, and other major surgical categories separately. Such a program could be conducted within the existing prehabilitation program infrastructure at major academic medical centers with relatively modest funding requirements.

Definitive Efficacy Trials with Hard Clinical Endpoints

The field requires at least one large, well-powered, multicenter randomized controlled trial with hard clinical endpoint primary outcomes (30-day mortality, major adverse events, hospital-free survival) rather than biomarker surrogate endpoints. Such a trial, powered to detect a 25 to 30 percent reduction in the primary endpoint (based on the effect sizes suggested by existing trials and cohort data) would require approximately 400 to 600 patients per arm for cardiac or major abdominal surgery, a sample size that is achievable within a multicenter collaboration but has not yet been assembled. The European Society of Anaesthesiology's prehabilitation research network, which has infrastructure for multicenter prehabilitation trials, represents a potential organizational platform for such an effort.

Mechanism Verification and Biomarker Validation

The mechanistic evidence for thermal preconditioning is compelling but largely derived from animal models and small human mechanistic studies. Direct verification in humans that preoperative HSP70 elevation mediates the clinical benefits (rather than serving as a correlated biomarker of the response to a beneficial intervention whose true mechanism lies elsewhere) requires appropriately designed mediation analyses within adequately powered randomized trials. Developing and validating rapid, point-of-care HSP70 measurement tools that could be used in clinical settings to confirm adequate preconditioning response before surgery would provide a practical tool for individualizing protocols and identifying non-responders who might benefit from protocol intensification or alternative strategies.

Long-Term Follow-Up Studies

The existing randomized trials have uniformly focused on short-term outcomes (30-day mortality, immediate post-operative biomarkers, hospital length of stay) without capturing long-term functional outcomes, quality of life, and healthcare utilization over the months to years following surgery. A structured long-term follow-up component within major trials, collecting patient-reported outcome measures, healthcare utilization data, and vital status at six months, one year, and three years post-surgery, would determine whether the short-term benefits of thermal preconditioning translate into sustained differences in the long-term surgical outcome trajectory. This is particularly relevant for orthopedic surgery patients, where the one to three year post-operative period of functional recovery and return to full activity may be substantially influenced by the quality of initial recovery facilitated by preconditioning.